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ABSTRACT

Role of multi-site phosphorylation in regulation of E(spl) M8 activity during
Drosophila neurogenesis
Mohna Bandyopadhyay

Notch signaling is an evolutionarily conserved pathway that regulates cell-fate
determination at various stages of development in invertebrate and vertebrate species. The
Notch pathway mediates juxtacrine signaling through a process termed as lateral inhibition
by which two equipotent cells adopt distinct cell fates. The functions of Notch have been
exceptionally well analyzed during neurogenesis in Drosophila, particularly during eye and
mechanosensory bristle morphogenesis. At the onset of neurogenesis, proneural bHLH
activators encoded by atonal (ato) or the achaete-scute complex (ASC) is expressed in
groups of cells, called proneural clusters (PNCs) in the eye and the bristle tissue
respectively. From each PNC, however, only a single cell becomes the neural progenitor,
the sensory organ precursor (SOP). This selection is mediated through E(spl) repressors, a
group of evolutionary conserved bHLH repressors and the terminal effectors of the Notch
pathway. Accumulating evidence suggest that repression of Ato/ASC by E(spl) occurs in a
phosphorylation dependent manner. Protein kinase CK2 phosphorylates E(spl)-M8, which
then undergoes a conformational change and antagonizes the proneural proteins. The work
described in this dissertation aims to provide a more detailed understanding of the
mechanism of neural repression by M8. The work described in Chapter 2 provides in vivo
evidence that multi-site phosphorylation of the C-terminal domain (CtD) of M8 may be
involved in regulation of repressor activity. Using phospho-mimetic variants of M8 we have
shown that both CK2 and MAPK motif in the CtD may be modulated for the protein to exhibit
neural repression. Multisite phosphorylation may act as a ‘switch’ controlling the activity and
onset of repression by M8 during neurogenesis. The studies in Chapter 3 demonstrate a
direct role of P-domain, a conserved phosphorylation domain of CtD, in autoinhibition model
of M8. The deletion variant studies provide strong evidence that the P-domain provides
critical autoinhibitory contact with HLH and/or Orange domain to regulate repression of
Ato/ASC. This study provides a fundamental reinterpretation of the mechanism by which
truncated protein, M8* encoded by m8 allele E(spl)D, that lacks the autoinhibitory domain,
elicits precocious Ato antagonism thus interfering with first phase of Notch signaling and
perturbing eye development. Our studies also implicate P-domain as a target of Slmb, a
subunit of E3 ubiquitin ligase that may give rise to ‘phosphodegron’ necessary for
proteasomal degradation and rapid clearance of M8. Together, the studies described in this
dissertation provide a mechanism of M8 regulation by posttranslational regulation to elicit
the effects of inhibitory Notch signaling during lateral inhibition.
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CHAPTER 1: Introduction

1

The development of single fertilized egg into a properly formed multicellular
(metazoan) organism is one of biology’s deepest and yet to be fully understood enigmas.
This, in large part, reflects the necessity for multiple (combinatorial) approaches such as
genetics, cell biology, biochemistry and biophysics, all of which are essential to understand
how a single totipotent cell (the fertilized egg) undergoes precise and progressive changes
in cell fates to give rise to a properly formed individual animal. Remarkably, the
developmental processes, which dictate the diverse cell fates, hinge upon only a handful of
signaling pathways that are highly conserved through evolution. These signaling pathways
ensure that cell proliferation, differentiation, migration, apoptosis, etc., are coordinated in a
highly precise manner during tissue formation, patterning and organogenesis.
The five conserved signaling pathways that are key to development are Notch (N),
Epidermal Growth Factor Receptor (EGFR), Decapentaplegic (Dpp), Hedgehog (Hh) and
Wingless (Wg). Over the years, analyses in various experimental model organisms have
outlined the core components and the architecture of these signal transduction pathways.
Nevertheless, the challenge before us is to understand how these pathways control the
formation of various tissues and organs, in light of the fact that they play reiterative roles
throughout development.
In the past few decades, remarkable progress has been made in our understanding
of the mechanisms underlying cell-cell signaling. It is, perhaps, not surprising that
perturbations of these signaling pathways, either through inappropriate activation or
inactivation, underlie various birth defects and human disease states. In addition, it is
becoming increasingly appreciated that polymorphisms in the components of these signaling
pathways manifest in numerous diseases with ‘sporadic’ (tissue-specific) incidence. It is
therefore important to understand the precise spatial as well as temporal coordination
between these biochemical and genetic circuits that regulates development, and this aspect
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remains a major challenge before us. This understanding is important to decipher tissuespecific molecular mechanisms that underlie developmental disorders and disease states.
Germane to the studies described in this dissertation (Chapters 2-4, see below), this
introduction focuses on two of these signaling pathways, i.e., Notch and EGFR, and
concludes with a discussion of the impact of phosphorylation on one (of several) effectors of
Notch signaling, a mechanism enabling the intersection of these two pathways via posttranslational regulation. This introduction reviews the conserved components of these
pathways, their signaling logic, their roles in two well-studied developmental paradigms, and
concludes with a section outlining gaps in our current knowledge. Because these pathways
coordinate cell fate specification throughout development, this review focuses on
development of the nervous system in arguably the preeminent genetic model, the fruit fly
Drosophila melanogaster.
Studies in Drosophila have, over more than a hundred years, served as a paradigm
and a springboard for understanding not only general principles of animal development, but
have provided some of the most sophisticated insights into how cell signaling controls cell
fate specification. In part this reflects a short generation time, the low expense of
maintaining fly stocks, a large collection of mutants, the ease of transgenic analysis, and a
battery of molecular, genetic and immunological resources, all housed at repositories that
are widely available to the research community.
The Notch Pathway
The existence of the Notch locus was revealed by the work of John S. Dexter in
1914, upon the identification of the (name giving) mutation called ‘Notch’. He described the
mutation as a heritable abnormality in fruit flies, characterized by ‘notching’ of the tips of
their wings. Later, Thomas Hunt Morgan, through studies of mutations in Drosophila,
identified the first allele of the Notch gene. The nomenclature was based on the ‘notched’
3

wing phenotype associated with the loss of wing tissue. Although the gene was identified,
its role in development remained largely obscure until 25 years later when David Poulson
reported that the complete loss of Notch function resulted in embryonic lethality (Poulson,
1937). His work on Notch mutants was the first to associate a gene whose activity was
specific for development in an organism.
Subsequent studies led to the discovery of additional genetic loci that were
necessary for proper Notch function, and the realization that aberrant Notch signaling elicits
neurogenic phenotypes (see below). The first detailed insights into the mode of action of
Notch signaling came from studies in Drosophila melanogaster and Caenorhabditis elegans,
which paved the way for better understanding the underlying mechanisms in higher
eukaryotes, including mammals (Greenwald, 1998).
As is the case for many genes, the number of Notch receptor subtypes differs widely
between species. While Drosophila has a single Notch receptor, C. elegans has two genes,
which code for Notch receptors, LIN-12 and GLP-1 (Greenwald et al., 1983). In contrast,
mammals have four distinct Notch receptors, Notch 1-4 (del Amo et al., 1993; Lardelli et al.,
1994; Uyttendaele et al., 1996; Weinmaster et al., 1992). It should, however, be noted, that
although the number of receptors may vary amongst the aforementioned taxonomic groups,
the basic mechanism of Notch signaling appears to be conserved (see below). As a focus
of the studies described in this introduction, the mechanism of Notch function will be
discussed mainly in the developmental context of Drosophila as a model system.
The Notch signaling pathway is involved throughout development, and regulates
neurogenesis, myogenesis, somitogenesis, oogenesis, angiogenesis, left-right symmetry,
formation of the cardiac and renal systems, and stem cell maintenance (Artavanis-Tsakonas
et al., 1999; Lai, 2004; Mumm and Kopan, 2000). More recent studies are revealing that
Notch plays additional roles in the adult, such as its impact on the circadian rhythms.
4

Despite these diverse contexts, this pathway mediates short-range (juxtacrine) signaling
between adjacent cells, and in an exclusively contact-dependent manner because both the
receptor and its ligands are membrane-bound proteins. This is underscored by the findings
that soluble forms of the ligand Delta have the capacity to interact with the receptor, but are
unable to mediate Notch signaling, and trigger tumorigenicity in cultured mammalian
fibroblasts (Li et al., 2007; Urs et al., 2008).
The Notch receptor signals through three primary modes. The first of these, lateral
inhibition, is the process by which Notch inhibits the default cell fate from a group of
equipotent cells. Consequently, lateral inhibition is necessary to ensure that from each
cluster of equipotential cells only a single cell is allowed to maintain the primary cell fate.
This process, the focus of my dissertation research, is discussed in greater details later in
this introduction. The second mode of Notch signaling is in cell fate specification, in part by
its role in asymmetric cell division. During asymmetric cell division, only one cell inherits a
Notch regulator. As a result, the two resulting daughter cells display differential Notch
activities, which, in turn, confer distinct cell lineages/fates. The third, boundary formation,
occurs when a population of cells induces Notch activity in nearby cells that leads to their
segregation into two distinct cell types. Although classically associated with binary cell fate
decisions, and in addition to the three modes of signaling mentioned above, Notch is also
involved in regulation of cell proliferation, maintenance of stem cells as well as apoptosis
(Artavanis-Tsakonas et al., 1999).
Notch Pathway and diseases
Given that Notch functions in diverse developmental contexts, it is perhaps
unexpected that mutations affecting Notch signaling elicit tissue/organ-specific congenital
abnormalities and have been linked to specific disease states. These include diseases
affecting various organs such as the liver, eye, kidney, vasculature and heart. Some of the
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inherited syndromes associated with abnormal Notch signaling include Alagille syndrome
(Artavanis-Tsakonas et al., 1999; Gridley, 2003; McCright et al., 2002), characterized by
organ and skeletal abnormalities, CADASIL, a disorder characterized by stroke and
dementia (Joutel et al., 1996; Penton et al., 2012), spondylocostal dystosis, a skeletal
abnormality (Sparrow et al., 2008), T-ALL, a T-cell acute lymphoblastic leukemia (Weng et
al., 2004), Hajdu-Cheney syndrome, characterized by severe and progressive bone loss
(Simpson et al., 2011), and neurodegenerative diseases such as Batten syndrome
(Colombo et al., 2013; John et al., 2002). In addition, defects in this pathway have been
linked to congenital heart diseases, the hematopoietic malignancy multiple myeloma,
multiple sclerosis, familial aortic valve disease, and other cancers (Garg et al., 2005;
Garside et al., 2013; High and Epstein, 2008; John et al., 2002). The broad roles of Notch
signaling and the wide spectrum of disorders manifesting upon aberrant signaling makes it
likely that the ‘threshold’ of Notch signaling required for its diverse tissue-specific functions is
distinct both quantitatively and/or qualitatively, which has previously been implicated in
studies on Notch in the Drosophila model organism (see below). Surprisingly, some of the
aforementioned developmental abnormalities are not fully recapitulated in the mouse model,
suggesting that our understanding of this pathway is still incomplete. It would seem that
studies in both invertebrate and vertebrate model systems are needed to illuminate
complexities in Notch signaling to impact basic and/or clinical research relevant to Notchrelated pathologies.
Components of the Notch pathway
The core components of the Notch pathway were identified through genetic analyses
in C. elegans and Drosophila. The pathway has a simple architecture where all the major
components are conserved from Drosophila to mammals (Fig. 1A). In Drosophila, the
pathway consists of a transmembrane Notch receptor, its ligands Delta (Dl) or Serrate (Ser),
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the downstream transcription factor Suppressor of Hairless (Su(H)), and the final effectorsthe basic Helix-Loop-Helix (bHLH) transcription repressors encoded by the Enhancer of split
Complex (E(spl)C) (Delidakis and Artavanis-Tsakonas, 1991; Schweisguth and Posakony,
1992). The E(spl)C, which is located on the third chromosome, encodes a family of
structurally similar bHLH repressors called Mδ, M, Mγ, M3, M5, M7 and M8 and their
common co-repressor Groucho (gro) (Delidakis and Artavanis-Tsakonas, 1991; Hartley et
al., 1988; Klambt et al., 1989). The E(spl) proteins function as repressors; this requires the
formation of homo/hetero-dimers as well as interaction with Gro (Alifragis et al., 1997; Giebel
and Campos-Ortega, 1997)kuzbanin. While the mechanistic reason for the Grodependency is well understood, the reason(s) why dimerization is critical to repression
remain unclear.
Structure of Drosophila Notch
The Notch receptor in Drosophila is a 300 KDa single-pass transmembrane receptor
(Fig. 1B). The extracellular domain contains a series of Epidermal Growth Factor (EGF)-like
repeats that are responsible for ligand binding. The Notch receptors of different animals
vary in the number of EGF-like repeats. Each EGF repeat is approximately 40 residues long
and contains six cysteine residues that are held together by three disulfide bonds (Fleming,
1998). The fruit fly Notch receptor has 29-36 EGF-like repeats (Fleming, 1998). The EGFlike repeats undergo a series of modifications via glycosylation, which are critical for
receptor-ligand interactions and are thought to influence signaling strength. The minimal
region of the Drosophila Notch receptor, which is essential and sufficient for binding to the
ligands Delta and Serrate encompass the EGF-like-repeats 11 and 12 (Rebay et al., 1991;
Xu et al., 2005)
Three highly conserved cysteine rich LIN-12/Notch repeats, the LNRs, follow the
EGF-repeats. The LNR is followed by a heterodimerization (HD) domain, which is adjacent
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to the transmembrane domain (Tien et al., 2009). The HD domain harbors the S2 cleavage
site, which helps to maintain the receptor in a metalloprotease-resistant conformation
(Gordon et al., 2007). Together, the LNRs and the HD domains sandwiched between the
ligand binding and the transmembrane regions of the protein comprise the negative
regulatory region (NRR), which helps to maintain Notch in a resting confirmation (Fig. 1B).
The cytoplasmic region of Notch contains several functional domains, represented by
an N-terminal recombination binding protein-J associated molecule (RAM) domain (Tamura
et al., 1995) followed by an ankyrin (ANK) domain and culminates in a long unstructured
linker that includes a variable trans-activation domain (TAD) (Kurooka et al., 1998). There
are seven ANK repeats, which represent the most conserved region of the cytoplasmic
region of the receptor. Each ANK repeat is comprised of 33 residues and together make up
an essential domain for Notch-receptor function. At the extreme end of C-terminal region is
a conserved proline/glutamic acid/serine/threonine-rich (PEST) motif that functions as a
degradation signal and regulates receptor stability (Kopan and Ilagan, 2009; Moretti and
Brou, 2013) (Fig. 1B).
Notch Ligands
Since Notch signaling is dependent on direct cell-to-cell interaction, the canonical
ligands that bind and activate the Notch receptors are single-pass transmembrane proteins
characterized by the presence of an N-terminal (NT) domain, followed by a DSL (Delta,
Serrate, LAG-2) domain and a varying number of EGF-like repeats (Chillakuri et al., 2012) .
The canonical Notch ligands belong to two classes, the Delta/Delta-like and the
Serrate/Jagged class. The Serrate/Jagged class of ligands has an additional domain of
cysteine rich repeats close to the transmembrane domain. Drosophila has two canonical
Notch ligands- Delta and Serrate. In contrast, there are five canonical Notch ligands in
mammals- Jagged-1, Jagged-2, DLL1, DLL-3 and DLL-4 (D'Souza et al., 2010).
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Regulation of Notch Signaling
Since the Notch pathway regulates numerous cell-fate specification events in
metazoan animals, deregulation of signaling underlies multiple developmental disorders
(see above). Hence, both the timing and strength of receptor activation are key steps to
regulate the pathway. A host of post-translational modifications starting with ligandmediated activation, receptor proteolysis and target selection are critical to the regulation of
Notch signaling. A brief discussion on the molecular events of regulatory mechanism of
Notch signaling is presented in the following section.
Receptor maturation
The Notch receptor undergoes three successive proteolytic cleavages in order to
take the form of a mature, membrane-anchored receptor (Fig. 2). The first proteolytic
cleavage, which is referred to as the ‘S1 cleavage’, occurs in the trans-Golgi complex and is
facilitated by the Furin-like convertases (Logeat et al., 1998). The cleaved receptor is then
targeted to the cell surface as a heterodimer composed of a Notch extracellular domain
(NECD) and a Notch intracellular domain (NICD) held together by non-covalent interactions.
In addition to this first proteolytic cleavage, the receptor undergoes several
glycosylation steps in the endoplasmic reticulum and the Golgi complex before it is targeted
to the plasma membrane as a mature receptor (Fig. 2). The multiple EGF-like repeats of the
extracellular domain are sites for glycolysation. After Notch is translated, the enzyme Ofucosyl transferase (O-Fut) adds the first fucose group to the EGF repeat 12 (Kopan and
Ilagan, 2009). Initially it was thought that this particular modification is essential for the
generation of a functional receptor (Okajima and Irvine, 2002). However, later studies in
Drosophila demonstrated that non-fucosylated Notch was able to be trafficked properly to
the cell membrane, interact with ligand and even able to mediate signaling (Okajima et al.,
2008; Stanley, 2007; Vodovar and Schweisguth, 2008). Subsequently, additional
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carbohydrate moieties are added to the fucosylated receptor, which is essential for Notch
signaling. In the Golgi apparatus, Fringe catalyzes the transfer of N-acetylglucosamine
(GlcNAc) to the EGF repeats of the Notch receptor (Haines and Irvine, 2003). Studies show
that these glycosyl modifications alter the strength of ligand interaction with the Notch
receptor and thus regulate its activity (as reviewed in vivo (Bray, 2006)). For example,
Fringe-mediated glycosylation has been shown to increase the affinity of Notch receptor for
the ligand Delta while reducing Serrate-binding (Bruckner et al., 2000; Xu et al., 2007).
More recently, another glycosyltransferase, RUMI, has been identified that adds O-glucose
to specific Ser residues in the extracellular domain of Drosophila Notch (Acar et al., 2008).
Unlike other glycosyltransferases, loss of RUMI leads to impaired Notch signaling in a
variety of developmental contexts, indicating that it is a general regulator of the Notch
pathway.
Ligand Binding and Receptor Activation
Canonical Notch signaling occurs when a ligand of the DSL (Delta and Serrate in
Drosophila, Jagged in mammals and LAG-2 in C.elegans) family present on one cell
interacts with Notch receptors present in the adjacent cell. Ligand binding leads to
activation of the receptor, which is regulated by a key proteolysis event at the S2 site within
the LNR region. The ADAM family of metalloproteases mediates this S2 cleavage (Fig. 2).
In the absence of the ligand, the LNR domain sterically hinders the HD domain to occlude
the S2 cleavage site. Ligand binding to the receptor changes the conformation of the LNR
region and exposes the S2 cleavage site, which is now available to ADAM proteases.
ADAM 10 (also known as Kunzbanian in Drosophila) is responsible for cleaving Notch
receptor at S2 site (Pan and Rubin, 1997). Additionally, endocytosis of Notch extracellular
domain into the ligand-expressing cell provides a mechanical force that “pulls” away the
protective LNR repeats from the HD domain to expose the S2 site (as reviewed in (Gordon
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et al., 2008). This process ensures that Notch activation only takes place in two adjacent
cells and only in the presence of ligand. This view corroborates the finding that soluble
ligands are insufficient to activate Notch receptor in cell culture (Sun and ArtavanisTsakonas, 1997). The S2 cleavage event is followed by further proteolysis at the S3 site in
the Notch extracellular truncation domain (NEXT) mediated by γ-secretase, which releases
the NICD (Okochi et al., 2002). Thus, regulated proteolytic events, ligand binding and
endocytosis of Notch receptor domain are crucial steps in receptor activation.
Target gene expression
The NICD released after the γ-secretase proteolytic event induces target-gene
transcription. Following its release, the NICD fragment translocates to the nucleus and
interacts with the CSL (CBF-1 in mammals, Su(H) in Drosophila and LAG-1 in C. elegans)
family of transcription factors via its RAM domain (Artavanis-Tsakonas et al., 1995; Bailey
and Posakony, 1995). This interaction switches the CSL repressors into transcriptional
activators, which then drive the transcription of the terminal effectors of the Notch pathway,
the bHLH E(spl)/HES repressor proteins (Fig. 2). Prior to its activation by NICD, the CSL
complexes with the co-repressors C-terminal binding protein (CtBP) and Groucho (Gro) and
recruits Histone deacetylases (HDACs) to maintain E(spl)/HES in a repressed state (Barolo
et al., 2002; Lai, 2002). NICD and CSL combine to recruit a co-activator such as
Mastermind (Mam) in Drosophila or Mam-like (MAML) in mammals (Petcherski and Kimble,
2000). Mam in turn recruits histone acetyl transferases (HATs) and p300, which stabilize
the transcription initiation complex and activates expression of target genes (Wallberg et al.,
2002). Subsequent phosphorylation of the NICD-CSL-MAM transcriptional complex
downregulates the activity and ensures degradation of the NICD. The PEST domain in
NICD undergoes phosphorylation by CDK8 and is then targeted for proteasomal
degradation by E3 ubiquitin ligase (as reviewed in (Kopan, 2012)). This leads to the
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termination of the Notch signal, and in those cases where Notch acts repeatedly, resets the
cell for the next round of signaling.
Eye and bristle development in Drosophila
The functions of Notch have been exceptionally well analyzed for neurogenesis
(Artavanis-Tsakonas et al., 1999; Mumm and Kopan, 2000), during which binary cell fate is
determined. The two external sensory organs of Drosophila, which have led to our
understanding of Notch pathway in neurogenesis, include the compound eye and the
mechanosensory bristles. The development of these sensory organs in a precise pattern
initiates during the larval stage and is completed during the pupal stage of development.
The cells of these two organs are generated from the organ-specific epithelial sheet (a
monolayer) known as the imaginal disc, which undergoes sequential specification and
differentiation achieved by spatially and temporally restricted gene expression of various
transcription factors. These two sensory organs provide excellent readouts of Notch
pathway activity as the bristles occupy invariant positions in the body and the repeating units
of the compound eye (ommatidia or facets) are arranged in a precise hexagonal pseudocrystalline array (Cagan and Ready, 1989; Cubas et al., 1991; Ready et al., 1976;
Schweisguth et al., 1997; Simpson et al., 1999). Hence, any changes in the Notch pathway
activity perturb the hexagonal arrangement of the ommatidia and thus the architecture of the
eye, as well as the position and the number of bristles on the body. Both of these defects
result in externally visible phenotypes and even subtle perturbations in these two sensory
organs are easily discernible by light microscopy. This initial observation of perturbation of
neurogenesis can be followed by immunohistochemistry on the eye-antennal disc or the
wing disc, parts of which give rise to the adult eye and thorax, respectively.
Notch Signaling and Lateral Inhibition
At the onset of neurogenesis, proneural bHLH activators encoded by atonal (ato) or
12

the genes of the achaete-scute complex (ASC) are expressed in groups of cells, called the
proneural clusters (PNCs) (Heitzler et al., 1996; Jarman et al., 1995; Jarman et al., 1994).
The activities of these proneural proteins drive the formation of the PNCs, in which all cells
have somewhat equal potential to adopt the neural fate (Dambly-Chaudiere and Vervoort,
1998). From each PNC, however, only a single cell will go on to become the neural
progenitor, the sensory organ precursor (SOP) (Fig. 3). This restriction of the SOP-fate to a
single cell from a PNC has been termed lateral inhibition (Simpson, 1990). During this
process, one of the cells of PNC gains an advantage over the others by producing higher
levels of Ato/ASC, and thereby expresses higher levels of Dl. This asymmetry in Dl levels
elicits activation of Notch in the adjacent cells of the PNCs (the non-SOPs). Specifically,
activation of Notch results in the cleavage and nuclear translocation of it’s intracellular
domain (NICD), where it associates with and activates Su(H) leading to the E(spl)
transcription (Bailey and Posakony, 1995) (Fig. 3). The E(spl) repressors along with Gro
then antagonize Ato/ASC to restrict the SOP fate in all but one cell of a PNC. In fact, Gro is
a corepressor essential for a large group of bHLH proteins; those encoded by the E(spl)C,
Deadpan and Hairy (Paroush et al., 1994). Consistent with this model, decreased Notch
pathway activity results in the emergence of multiple SOPs from each PNC. This
supernumerary SOP specification results in a rough eye and ectopic and closely juxtaposed
bristles.
Notch Signaling during Drosophila eye development
The remarkably precise hexagonal geometry of the compound eye of Drosophila has
afforded an ideal system to understand the role of different signaling pathways in pattern
formation. The Notch pathway is central to Drosophila eye development. The compound
eye of Drosophila is composed of ~800 ommatidia arranged in a hexagonal lattice (Fig. 4).
Each ommatidium is composed of eight photoreceptors (R1-R8- the retinula cells), twelve
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accessory non-neuronal cells such as pigment cells and cone cells, and an interommatidial
bristle (IOB). During the third larval stage (instar), eye morphogenesis initiates at the
posterior margin of the eye-antennal disc, a monolayer neuro-epithelium that is the
progenitor of the retina. Retinal neurogenesis starts with the specification of the R8
photoreceptors (Jarman et al., 1994). R8 specification occurs in a moving wave of
differentiation, called the morphogenetic furrow (MF) (Fig. 4), which is discernible in
unstained tissue due to constriction of the cells mediated by localized polarization of actin.
R8 specification is a critical and essential first step during eye morphogenesis as it
subsequently recruits all other cell types in the assembling ommatidia. In “null mutation” of
ato (ato1) no R8’s are specified and the eye is lost. Because of this vital role played during
ommatidial formation, R8 cells are referred to as the ‘founding’ photoreceptors. While R8
selection occurs within the MF, all secondary photoreceptor recruitment occurs posterior to it
(Wolff and Ready, 1991). The movement of the MF from the posterior margin of the eye
disc to its mid-point (its final limit) occurs in 48 hrs. Thus analyses of the mid-late L3 stage
eye disc provide a broad temporal window to understand the mechanisms of specification of
various cell types during neurogenesis.
During R8 ontogeny, Notch serves biphasic roles. At stage-1, the anterior margin of
the MF, cells begin to express low levels of ato cell autonomously to form the ‘Ato-stripe’.
(Fig. 4) This proneural enhancement step is induced by Notch activation (Baker et al.,
1996). Ato then dimerizes with Daughterless (Da), eliciting high levels of ato transcription.
This process called ato auto-activation generates pre-R8 clusters, the intermediate groups
(IGs) with somewhat equal potential to become an R8. At stage-2/3 of the MF, a single R8
is non-autonomously selected from each IG by lateral inhibition (Fig. 4). During this
process, Notch mediates expression of E(spl) proteins, which repress Ato in all but a single
cell of an IG (Ligoxygakis et al., 1998). By stage-4, single patterned R8s emerge and these
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cells are marked by the sustained expression of the Ato target gene senseless (sens) whose
expression is first observed at the three-cell Ato positive cluster (Nolo et al., 2000; Pepple et
al., 2008). After this point in R8 ontogeny, Sens expression continues to be maintained in
all differentiated R8s throughout the developing eye disc. Posterior to the MF, R8s emerge
in a precise phase-shifted manner, such that R8s of one column are out of phase to those in
the adjacent column. This alternating spacing (patterning) is vital for the hexagonal
architecture of the adult eye. Consistent with this view, targeted overexpression of Ato in
the MF elicits the specification of supernumerary R8s, and results in a rough eye phenotype
(White and Jarman, 2000). The R8s then systematically recruit surrounding uncommitted
cells as the R2/R5, R3/R4, R1/R6 cells, concluding with the specification of the R7 cell
(Cagan and Ready, 1989) (Fig. 4). All of these cell fate specifications also involve Notch
signaling (Fanto and Mlodzik, 1999; Tomlinson and Struhl, 2001).
Notch Signaling during Drosophila bristle development
The external sensory organs of Drosophila also include mechanosensory bristles of
the peripheral nervous system. The two types of bristles that have been studied extensively
to understand neurogenesis are the machrochaetes and the interommatidial bristles (Fig. 5).
The number and position of these bristles are invariant and are regulated by Notchmediated lateral inhibition (Hartenstein and Posakony, 1990). Each bristle contains four
distinct types of cells; a socket cell, a sheath cell, a shaft cell and a neuron.
Each bristle arises from a single precursor cell termed the sensory organ precursor
(SOP), which is selected from a group of equipotent cells, the PNCs. Although SOP
specification occurs at third instar larval stage, bristle morphogenesis does not begin until
the pupal stage. Unlike the eye, however, expression of ASC proneural activators is
independent of Notch signaling and instead depends on pre-pattern factors (Calleja et al.,
2002). The SOP is selected from the PNC by lateral inhibition in a manner akin to the R8
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cell. In this case, the cell expressing highest level of proneural activators encoded by the
Achaete-Scute gene complex in response to pre-pattern factors is destined to become the
SOP and in turn initiates lateral inhibition via the E(spl) repressors in the adjacent cells of
the PNC by activating Notch (Artavanis-Tsakonas et al., 1999; Castro et al., 2005; Giebel
and Campos-Ortega, 1997). The events after SOP selection are however different from
those following R8 specification. The SOP undergoes two asymmetric cell divisions to
generate the four distinct cell types characteristic of the bristle. The SOP at first forms the pI
neuroblast, which then divides asymmetrically to give rise to the pIIa and pIIb cells.
Asymmetric division of the pIIa cells generates external socket and shaft cells, which form
the external structures of the bristle (Fig. 5). The pIIb cell, on the other hand, divides
asymmetrically to give rise to a glial cell and the third order precursor called the pIIIb cell.
Asymmetric division of pIIIb cell gives rise to the two internal cells of the bristle, the neuron
and the sheath cell (Fig. 5).
A body of genetic evidence supports the reiterated roles of Notch signaling in bristle
development. For example, loss of Notch function prior to SOP selection leads to the
specification of extra SOPs from each PNC. In adult flies, each of these extra SOPs goes
on to form a complete bristle, which manifest as ectopic and closely spaced bristles
(Campos-Ortega, 1998; Skeath and Carroll, 1991). On the other hand if Notch function is
lost after SOP selection, the stoichiometric sister cell fates become skewed resulting in split
bristles or missing bristles (Bray, 1997; Campos-Ortega, 1997). A split bristle reflects a
defect in the asymmetric division of the pIIa cell, which transforms a socket cell into a shaft
cell. On the other hand, a missing bristle can be a manifestation of either the loss of SOP,
itself, or a defect in the asymmetric division of SOP. A defect in the asymmetric division
gives rise to two pIIb cells, which result in the specification of two sets of neurons and
sheath cells. Because the shaft and socket cells, the external components of the sense
organ are missing, this manifests as a missing bristle.
16

E(spl)-C complex and bHLH repressors
E(spl)-bHLH repressors are the terminal effectors of the Notch inhibitory pathway
during eye and bristle development. These proteins repress Ato/ASC during the time of
lateral inhibition and restrict neural competency to a single cell of the PNC. The E(spl)
complex (E(Spl)C), encompasses ~60 Kb region on the 3rd chromosome and encodes 7
structurally similar bHLH proteins (Mγ, Mδ, Mβ, M3, M5, M7 and M8) (Fig. 6), four Bearded
family member (BFM) proteins (Mα, M6, M4 and M2), one protease inhibitor, kazal-m1 and
the distal, non-bHLH protein Gro (Delidakis and Artavanis-Tsakonas, 1991; Lai et al., 2000;
Wurmbach et al., 1999). Gro protein is known to physically interact with the E(spl)-bHLH
repressors and is needed for their function (Paroush et al., 1994). Recent studies have
shown that the BFM proteins function as inhibitors of Neuralized, an E3 ubiquitin ligase,
which is necessary for ubiquitinylation and subsequent endocytosis of the Notch ligands,
Delta and Serrate (Bardin and Schweisguth, 2006; De Renzis et al., 2006). This step is
necessary for ligand activation.
The E(spl)-locus is conserved across 12 Drosophila species and reveals remarkable
molecular synteny with respect to both the number of homologs and their position relative to
one another (Fig. 6). Given estimates of evolutionary distances between these 12 species
(Beverly and Wilson, 1984), it appears that the E(Spl)C locus has remained largely
unchanged for over 50 myr. In addition, the conservation of consensus sites for several
protein kinases in specific members presents a unique opportunity to better understand how
these proteins are regulated during development (see below). Initial studies revealed that
over-expression of any E(spl) protein elicited loss of bristles and the SOPs (Giebel and
Campos-Ortega, 1997; Nakao and Campos-Ortega, 1996). Consequently, these proteins
have been considered to be functionally redundant, a view that also extends to their
mammalian homologues, the HES proteins. It has been argued that 'redundancy' is an
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oversimplification, as the order of the seven E(spl) genes and their direction of transcription
is conserved over ~60 myr of Drosophila evolution (Maier et al., 1993).
Over the years, several studies have sought to identify the functional domains and
the mechanism of neural repression by E(spl) proteins. All E(spl) bHLH proteins have in
order from the N-terminus, a basic domain (DNA binding), an HLH domain (dimerization), a
second HLH region, the Orange domain (interaction with Ato/ASC) and a C-terminal WRPW
motif (Gro-binding) (Fig. 7). While these domains are highly conserved between individual
E(spl) members, their length and/or sequence heterogeneity is largely confined to the Cterminal domain (CtD), the region between Orange and WRPW. This region was therefore
thought to not be important for repressor activity, but studies conducted in our lab are
revealing that the CtD plays an important role in regulating repression in vivo. Specifically it
was shown that the CtD of M5, M7 and M8 harbors a highly conserved site for
phosphorylation by the kinase CK2 (Fig. 7), one that mediates both E(spl)-CK2 interactions
and results in their phosphorylation. These studies thus raised the possibility that these
three E(spl) members are regulated by post-transcriptional modification (Trott et al., 2001).
Although much time has been spent investigating the mechanism of neural
repression by E(spl) members, no universal mode of action has emerged. It was initially
proposed that E(spl) proteins bind to specific DNA elements called the N-box sequence in
target genes, recruit Gro and elicit their repression (Tietze et al., 1992; Van Doren et al.,
1994). However, it was subsequently shown that deletion of N-box from ASC enhancers
failed to impair repression in vivo. Moreover, the enhancers of Ato, a gene vital for eye
development and whose expression pattern is refined by E(spl)-M8, lacks any credible Nbox like sequence, suggesting alternative mechanisms underlie repression by these
proteins. A more recent study proposed that E(spl) proteins directly interact with enhancerbound ASC/Atonal proteins and regulate repression via this protein-tether mechanism
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(Alifragis et al., 1997; Giagtzoglou et al., 2003; Gigliani et al., 1996). These interactions are
thought to involve the Orange domain of E(spl) proteins, a proposal validated by
biochemical and yeast-two hybrid assays, where E(spl) members have been shown to
(physically) interact with ASC members, Atonal and their co-activator Daughterless (Dawson
et al., 1995; Giebel and Campos-Ortega, 1997; Gigliani et al., 1996).
Role of E(spl) members in eye and bristle development
Initial studies involving SOP and bristle development have led to the notion that
transcription and accumulation of E(spl) proteins, was by itself, sufficient for neural
repression (Giebel and Campos-Ortega, 1997; Nakao and Campos-Ortega, 1996). In
contrast, studies in the eye development rendered different results. In the developing eye,
the loss of E(spl) did in fact compromise lateral inhibition and result in excess R8
specification, but ectopic expression of M5, M7 and M8 did not elicit a dominant loss of R8
cells (Ligoxygakis et al., 1999). The inactivity of M5 and M7 may reflect the fact that these
two members of the E(spl) family are not expressed at this stage of eye development and
are thus dispensable for R8 specification and/or patterning (Cooper et al., 2000). However,
endogenous M8 is expressed in the MF during R8 specification and its mutation, the E(spl)D
allele, has also been shown to severely affect R8 patterning and eye formation (see below).
Based on these distinct developmental outcomes it was suggested that M5 and M7 must be
qualitatively different than M8, a contention, which remained largely unresolved.
The dominant allele E(spl)D was first identified in 1956 based on its ability to impair
eye formation when combined with the split allele of Notch (Nspl) (Tietze et al., 1992;
Welshons, 1956, 1965). It was in fact the ‘enhancement’ of the split eye defect of the Notch
allele, that led to the nomenclature as ‘E(spl)’. E(spl)D codes for a truncated protein
referred to as M8*, which lacks 56 residues of the CtD. Despite not binding to Gro as it
lacks the WRPW motif, M8* displays exacerbated repression of Atonal, thereby blocking R8
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birth and eye development. Because M8* lacks the WRPW motif and hence has no ability
to bind its co-repressor, it has been suggested that E(spl)D is a ‘Gro-independent
hypermorph’ (Nagel et al., 1999). Surprisingly, such a developmental defect could not be
recapitulated simply by removal of the WRPW motif from a full-length M8. This paradox was
addressed by the late Dr. Campos-Ortega, who presciently proposed that the CtD of M8
may have a regulatory influence on E(spl)-M8 activity. However, the nature of this
regulation remained unknown until the finding that this region between Orange domain and
WRPW motif is a target for phosphorylation (Karandikar et al., 2004). It was then that the
biochemical mechanism of repression by E(spl)-M8 began to become more clear.
Regulation by E(spl) repressors is phosphorylation dependent
A role for CK2 emerged from the cloning of m7 transcript based upon its interaction
with CK2 in multiple (yeast) two-hybrid screens. Follow up studies revealed that CK2
interacted with only three of the seven E(spl) proteins, M7, M8 and M5. This interaction was
mapped to the CtD region, which uncovered a highly conserved consensus for CK2 (Trott et
al., 2001). This motif in the case of E(spl)-M8 is S159DCD (Ser-Asp-Cys-Asp). Subsequent
to these studies, it has been found that HES6, the mammalian homolog of E(spl)-M8,
harbors a similar phosphorylation motif that is also modified by CK2 in vitro (Gratton et al.,
2003b). These results raise the possibility that E(spl) phosphorylation by CK2 is a key
regulatory step in Notch signaling during lateral inhibition.
Follow-up studies investigated the role of CK2 in repression by M8, using variants
that replace the CK2-phospho acceptor Ser159 with Asp or Ala. The Ala variant (M8S159A)
renders the protein non-phosphorylatable whereas the Asp modification (M8S159D) mimics
the hyper-phosphorylated state. Overexpression of wild type M8 led to loss of
interommatidial bristles (IOBs) and the macrochaetes (MCs) but failed to elicit any
ommatidial defects. Also, no eye defects were seen with the non-phosphorylatable isoform,
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M8-S159A. However, overexpression of M8-S159D elicited strong loss of R8s and a severe
reduction of the eye (Karandikar et al., 2004). The R8/eye defects of M8SD are virtually
identical to those of M8* (Nagel et al., 1999) which lacks the CtD and its resident CK2 site.
Furthermore, yeast two-hybrid assays reveal that M8* and M8-S159D interact with Ato with
equal strength, whereas M8 or M8-S159A do so only weakly. It was thus proposed that the
CtD region likely autoinhibits the Orange domain, previously implicated in Ato binding (JafarNejad et al., 2003). Phosphorylation displaces this 'cis' interaction permitting repression
(Fig. 7). Consequently, the truncation of CtD in M8* removes this regulatory region, thereby
bypassing autoinhibition and resulting in a protein that constitutively binds to Ato. If so, it
would suggest that CK2 regulates the lateral inhibition mediated by M8. Consistent with
these findings, targeted knockdown of CK2 elicits supernumerary R8s from the IGs in the
developing retina, and to supernumerary MCs and SOPs in the bristle lineage (Bose et al.,
2006). These results reveal a key role for CK2 in the control of E(spl) activity during Notchmediated lateral inhibition, and that this kinase regulates E(spl)/Notch functions in broader
contexts. In a similar manner, CK2 modifies HES6 and this post-translational modification
(PTM) is essential for the formation of a HES6-HES1 complex. Thus the role of CK2 in
promoting protein-protein interactions between two classes of bHLH proteins appears to be
highly conserved. However, the developmental significance of the HES6 phosphorylation
and the regulated formation of HES6+HES1 dimer in humans remains unexplored.
The expression of M8 or M8SD in the bristle lineage elicited a loss of MCs with equal
severity, a stark contrast with respect to the results seen in the eye (Karandikar et al., 2004).
The difference in results between eye and bristle led to the suggestion that role of CK2
might be dispensable in ASC antagonism during bristle development, but that it plays a
critical role in eye development. It is possible that the absence of a role for CK2 in the
bristle formation reflects a limit phenotype, a function that is not discernible by the approach
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of ectopically expressed proteins.
The ‘autoinhibition’ Paradox
In line with the autoinhibition model, one would expect that both M8SD
(phosphomimetic variant) and M8* (lacking the CtD) should be constitutively active
repressors of Ato and should enable activity to be evaluated at three critical stages of R8
birth. If anything, their repressive activity should be maximal at stage-1, where Ato levels
are the lowest, as compared to that at stage-2/3 of the MF, where Ato levels are at the
highest and have achieved a ‘threshold’ sufficient to drive birth of the R8s.

However,

contrary to this prediction, the dominant eye defects of M8* and M8SD have been found to
be MF stage-specific. It appears that the dominant eye defects of M8SD are stage-2/3
specific where lateral inhibition refines R8s from PNCs. In contrast, M8* elicits a severely
reduced eye only at stage-1 of the MF, but fails to exhibit any activity at stage-2/3. If
phosphorylation by CK2 was necessary and sufficient to overcome the autoinhibited state,
M8SD should have also elicited loss of R8s/eye upon expression at stage-1 in a manner
akin to M8*. The inactivity of M8SD at stage-1 therefore raises the possibility that, while
important, CK2 is insufficient to activate M8 on its own. If so, are other regulatory enzymes
involved?
The possibility of M8 undergoing secondary modifications was hypothesized given
that the P-domain conserves a number of Ser residues in addition to that which is modified
by CK2 (Ser 159). This clustering of Ser residues within the CtD is not only conserved in
Drosophila M5/7, but also in murine and human HES6. In the case of HES6, secondary
phosphorylation by MAPK, an effector of Epidermal Growth Factor Receptor (EGFR)
signaling, has been demonstrated in cell lines, but how this regulates HES6 activity during
development has not been reported. Interestingly, upstream of the CK2 site in Drosophila
M8 lies a PxSP motif, which meets the strict consensus for modification by MAPK. Although
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the developmental consequences of phosphorylation of HES6 by MAPK are unknown, the
possibility arises that multisite phosphorylation by CK2 and MAPK could be essential for
regulation of repression by Drosophila E(Spl) proteins. If M8 activity were to require both
CK2 and MAPK, it would establish that EGFR signaling potentiates Notch pathway activity
and that these two signaling pathways do not always act in an antagonistic manner, and
provide important insights into the complex roles of EGFR signaling during eye development
(see below).
Protein Kinase CK2
CK2 is a conserved Ser/Thr protein kinase present ubiquitously in all eukaryotes. It
is a highly conserved kinase that plays critical roles in diverse cellular and biochemical
events such as gene expression, cell cycle progression, cell signaling, DNA replication and
repair, transcription, translation and apoptosis (as reviewed in (Meggio and Pinna, 2003)).
The kinase was first isolated and identified from rat liver extracts in the laboratory of Eugene
Kennedy (Burnett and Kennedy, 1954). The protein was aptly named ‘protein
phosphokinase’ for its ability to catalyze the addition of phosphate (from ATP) to Ser/Thr
residues on the protein casein. However, casein is not a natural (physiological) target of
CK2 and thus no biological relevance could be established behind this phosphorylation
effect. In 1955, seminal work from Edmond Fischer and Edwin Krebs’ lab demonstrated that
phosphorylation is an important biochemical step for regulating enzyme activity.
Specifically, they showed that glycogen phosphorylase is activated by cAMP-dependent
protein kinase (PKA) (Fischer and Krebs, 1955). This discovery has been the foundation of
studies identifying and characterizing protein kinases present in biological systems, and
efforts to analyze their roles in regulating diverse cellular functions such as cell division,
DNA replication, transcription and translation, animal development, etc.
During the purification process of Casein Kinase in Jolinda Traugh’s laboratory, two
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forms of the enzyme were identified based on their order of elution in column
chromatography and consequently these two activities were named Casein Kinase I and II
(Hathaway and Traugh, 1979). Following purification, antibodies specific for mammalian
CK2 were generated which demonstrated cross-reactivity with homologous enzymes from
Drosophila and worms (Dahmus et al., 1984). Furthermore, it was shown that the CK2α
subunit from Drosophila, human and worms can functionally substitute for one another
(Bidwai et al., 1992; Padmanabha et al., 1990). Together, these observations indicate that
CK2α is universally conserved in both structure and function in all eukaryotes.
Biochemistry of CK2
The CK2 holoenzyme is a hetero-tetramer that is composed of two catalytic (α)
subunits and two regulatory (β) subunits (Glover et al., 1983; Padmanabha and Glover,
1987). The α-subunit displays the catalytic activity and can utilize either ATP or GTP as a
substrate (Glover et al., 1983). The catalytic activity of monomeric CK2α is stimulated by
the regulatory β-subunit, which modulates substrate recognition and provides stability to the
holoenzyme (Cochet and Chambaz, 1983). The mammalian enzyme contains two isoforms
of the catalytic subunit (α and α’) that are encoded by two distinct genes whereas a single
gene specifies the regulatory β-subunit.
When compared to other protein kinases, CK2 can utilize either ATP or GTP as
phosphoryl donor to phosphorylate Ser/Thr residues (Dahmus et al., 1984; Glover et al.,
1983; Hathaway et al., 1980). CK2 preferentially targets acidic substrates and recognizes a
unique consensus sequence at its target site. This consensus sequence is S/T-D/E-x-D/E,
in which the acidic residues at positions n+1 and n+3 are rate limiting for phosphorylation
(Kuenzel and Krebs, 1985; Kuenzel et al., 1987). Additional acidic residues at the N- and Cterminus of this microdomain further enhance phosphorylation activity of CK2 towards the
target protein. The effect of the acidic residues in the microdomain can be biochemically
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mimicked by pSer/pThr, which generates hierarchical sites thus increasing the likelihood of
progressive phosphorylation by CK2. The most extreme example of hierarchical
modification is Nopp140, a protein that is progressively modified by CK2 at 72 sites (Meier
and Blobel, 1992).
CK2 and its role in development
Since its discovery in 1953, a range of targets for CK2 has been identified by
genetic, biochemical and computational studies. The kinase has been thought to play an
essential role in different branches of cell biology, which includes cell-cycle control and cell
proliferation, circadian rhythmicity, cell signaling and animal development and even in
learning and memory. Its role as a cell cycle regulator was first observed when the
stimulation of mammalian cells in culture with the mitogen Epidermal Growth Factor (EGF)
elicited oscillations in the levels and activity of CK2 (Sommercorn et al., 1987). Moreover, a
synchronous oscillation in CK2 activity was seen with G1 to S and G2 to M phase transitions
in the mammalian cell cycle, results since corroborated by the isolation and analysis of
temperature-sensitive alleles of yeast CK2 (Hanna et al., 1995; Rethinaswamy et al., 1998).
In another study, it was shown that deletion of the genes encoding the catalytic subunit of
yeast CK2 (CKA1 and CKA2) resulted in a cell death, and cells depleted of CK2 displayed a
‘pseudomycelial’ or ‘Shmoo’ morphology, a classic cell division cycle (CDC) phenotype
reflecting the uncoupling of cell growth from cell division in budding yeast (Padmanabha et
al., 1990). The most unique role of CK2 is perhaps displayed during Theileriosis, a B- and
T-cell lymphoproliferative disorder in cattle. It was the pioneering work of Dr. Ole-MoiYoi, a
veterinarian in Kenya, which displayed that cattle exhibiting the symptoms of this disease
invariably harbored the parasitic protozoa, Theileria parva, in their circulatory system. His
work subsequently demonstrated that this parasite preferentially infects B- and T-cells and
overexpresses a unique secretory from of CK2, which accumulates in the cytosol of the host
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cell (ole-MoiYoi, 1995; ole-MoiYoi et al., 1993). This parasite-derived CK2, which bears
striking similarity with the normal (mammalian) variant of the kinase, likely deregulates the
normal control of the cell cycle, which then elicits the development of lymphomas.
In addition, CK2 has been shown to associate with mitotic spindles and the
centrosomal apparatus (Yu et al., 1991). It also interacts with vital regulators of cell division
and replication checkpoint controls and targets a number of proto-oncogene-derived
proteins such as Myc, Myb, Fos and Jun (Luscher et al., 1989; Winkler et al., 2000).
Besides its role in development of tumors, CK2 has been closely linked to metastasis, for
which substantial efforts are underway to design specific inhibitors of this enzyme and
suppress the detrimental effects.
Given the vital role of CK2 in diverse biological processes, significant efforts have
been made to characterize the large number of targets of CK2. High throughput techniques
and availability of genomic sequences have made it possible to identify a large number of
targets for CK2. These interactions include proteins involved in various types of cellular and
biological functions such as DNA replication, transcription and translation, cell polarity and
development, cytoskeleton architecture and cancer (reviewed in (Meggio and Pinna, 2003)).
Therefore, the loss of CK2 elicits cell lethality in all unicellular and metazoan organisms.
Drosophila CK2
Drosophila CK2 was first purified from embryos and similarly to its mammalian
counterpart was shown to be a tetramer, composed of two α subunits and two β subunits
(α2β2 holoenzyme). A single CK2α gene located on the 3rd chromosome encodes the
catalytic subunit, whereas the regulatory subunit is encoded by CK2β gene on the X
chromosome (Bidwai, 2000).
To date, two spontaneous mutations of the CK2α gene has been identified based on
their ability to elicit defects in the circadian clock. These are known as Timekeeper (Tik),
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and its partial revertant, called TikR (Lin et al., 2002). Tik harbors two substitutions, M161K
and E165D. The M161K substitution is located within the ATP-binding pocket, thus interfering
with the enzymatic activity of CK2 (Rasmussen et al., 2005). Accordingly, Tik is
homozygous lethal and the lethality is manifested at first instar larval stage. The second
substitution, E165D lies in a highly conserved motif, H E165NRKL, which mediates physical
interaction between human CK2α and protein phosphatase PP2A (Heriche et al., 1997).
Although thought to be a silent mutation at first because it involved a conservative
replacement, the importance of E165D mutation was soon realized as it impairs
downregulation of phosphatase activity. Thus, Tik has been aptly suggested to be a ‘double
hit’, inactivating CK2 activity on one hand and enhancing PP2A activity on the other hand
(Kunttas-Tatli et al., 2009).
TikR was identified as a spontaneous revertant allele, based on its ability to partially
compensate for the circadian clock defects in Tik/+ animals. In addition to the two mutations
already present in the Tik allele, TikR harbors an R242G (Arg to Gly) substitution and a
deletion of seven internal amino acids (234-240). Consequently, TikR is also homozygous
lethal, manifesting its lethality at first instar stage (Lin et al., 2002). Studies indicate that
TikR is insoluble, which points to defects in protein folding mechanism, a defect not seen
with Tik. Moreover, unlike wild type CK2α or mutant Tik, the TikR protein does not interact
with CK2β, an interaction, that is essential for tetrameric holoenzyme assembly (KunttasTatli et al., 2009). These observations led to the view that Tik integrates into and ‘poisons’
the endogenous holoenzyme, thus compromising its activity. In contrast, since TikR is
unable to assemble into the holoenzyme, it shows a revertant behavior in context to the
circadian clock where halve dosage of CK2 (TikR/+) may still be sufficient to maintain nearnormal functionality of circadian rhythms. Apart from clock defects, neither Tik nor TikR,
display any overt developmental abnormalities in heterozygous condition, indicating that the
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residual levels of CK2 are sufficient for normal developmental functions of the cells/tissues.
Recently, a third allele of CK2α, CK2MB0047 has been described that harbors a
transposable minos element in the 5’UTR (Bellen et al., 2004). Unlike, Tik or TikR,
CK2MB0047 homozygotes manages to complete all three larval stages, but manifest in lethality
at the pupal stage. This indicates that CK2MB0047 is a hypomorph and consistent with its
characteristic fails to elicit any eye or bristle defects in heterozygous state.
An allele of CK2β (andante) also displays clock defects. The mutant protein fails to
form a stable holoenzyme in vivo. However, in vitro analysis with the human variant of
andante challenges this idea, and the mechanism underlying the clock defect in Drosophila
remains unresolved (Rasmussen et al., 2005). Homozygous andante flies are viable,
indicating that it is a hypomorphic allele (Akten et al., 2003).
The Epidermal Growth Factor Receptor (EGFR) Pathway
The Epidermal Growth Factor Receptor (EGFR) Pathway is a conserved pathway
that regulates diverse processes critical for metazoan development, ranging from cell
proliferation and survival to cell-fate specification to differentiation (Doroquez and Rebay,
2006). Reflecting this importance, several efforts have been made to understand the signal
transduction and the underlying mechanism of each member involved in this pathway
(Yarden, 2001). The pathway has been studied extensively in Drosophila, C.elegans and
mammalian cell lines and several computational models have been analyzed to understand
its dynamics (Schoeberl et al., 2002; Voas and Rebay, 2003; Wassarman et al., 1995).
EGFR Receptor and Ligands
EGFR is a transmembrane receptor belonging to the family of receptor tyrosine
kinases. These receptors are anchored in the cell membrane and contain an extracellular
ligand-binding domain, a short hydrophobic trans-membrane region, and an intracytoplasmic tyrosine kinase domain. In Drosophila and C.elegans, the receptor is coded by
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a single gene namely Drosophila EGF receptor (DER) and let-23 respectively. Mammalian
EGFR consists of four members, which include EGFR/ErbB1/HER1, ErbB2/HER2/Neu,
ErbB3/HER3 and ErbB4/HER4 (Yarden, 2001).
In the Drosophila system there are four activating ligands- Spitz (Spi), Keren (Krn),
Gurken (Grk) and Vein (Vn) and one secreted inhibitor Argos (Aos) (Neuman-Silberberg and
Schupbach, 1993; Reich and Shilo, 2002; Rutledge et al., 1992; Schnepp et al., 1996). Spi,
Krn and Grk are all synthesized as membrane-bound precursors and are subsequently
cleaved by a Rhomboid family protease to be secreted (Urban et al., 2002). The membrane
protein Star plays a role in the EGFR pathway by trafficking the ligand precursors from the
ER to the Golgi where they can be cleaved by Rhomboid for secretion (Lee et al., 2001).
Spi is the principle ligand activating the DER pathway in the majority of developmental
contexts, including Drosophila eye morphogenesis, while Krn and Grk are less frequently
involved (Freeman, 1994). Vn belongs to the Neuregulin family and is utilized in a number
of tissues such as in the wing, muscle attachment sites and distal leg regions (Campbell,
2002; Yarnitzky et al., 1997). The inhibitory ligand, Aos is unique to Drosophila so far, as no
mammalian/worm homologue has been identified. DER signaling leads to enhanced aos
expression, which suggests that it plays a negative feedback loop role, thus regulating
EGFR pathway output (Wasserman et al., 2000). Given the import of this negative feedback
loop, it remains enigmatic why a mammalian counterpart has remained unidentified.
In mammals the ligands that regulate ErbB receptors can be separated into two main
groups. ‘EGF agonists’ activate EGFR and Neuregulins that bind ErbB3 and ErbB4 (Yarden
and Sliwkowski, 2001). There are no known ligands for ErbB 2 and it is thought to play a
role in EGFR pathway by forming heterodimers with other ligand-activated ErbB family
members. In C.elegans, the ligand for EGFR is Lin-23. It is a soluble TGF-α-like ligand
whose roles have been extensively studied during vulva development.
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EGFR pathway activation
In the absence of ligand, EGFR is monomeric and the cytoplasmic tail shows no
kinase activity. When ligand binds to the extracellular domain of the receptor, it induces
receptor homo- or hetero-dimerization, which leads to subsequent activation of the intrinsic
tyrosine kinase domain. The cytoplasmic tail of the receptor undergoes ‘transphosphorylation’ where one receptor monomer phosphorylates the Tyrosine residues of the
other binding partner. The phosphorylated residues of the dimerized receptor serve as
docking sites for downstream signaling proteins. The activated receptors also mediate
signals by phosphorylating target proteins. EFGR hetero-dimerization is a unique feature of
the mammalian system (Schlessinger, 2000). In contrast, Drosophila and C. elegans exhibit
only homodimerization due to the presence of only one isoform of EGFR. Receptor
heterodimerization has been attributed to diversity and specificity of EGFR function and to
signal output.
MAPK pathway
Among all the different signaling pathways activated by EGFR, the MAPK pathway is
a widely studied and critically important signal transduction mechanism for regulating cell
proliferation and cell survival. The pathway works via a three-tier phosphorylation cascade
in which the terminal (effector) kinase, MAPK, is activated upon phosphorylation by mitogen
activated protein kinase (MAPKK), which in turn is activated upon phosphorylation by
MAPKKK. Activated MAPK either phosphorylates proteins in the cytoplasm or in the
nucleus, targeting various transcription factors and thus regulating transcription (Reiser et
al., 1999). To date, six different MAPKs have been identified in mammals; extracellular
regulated kinases (Erks 1/2, Erks 3/4, Erks 5, Erks 7/8), Jun N-terminal kinase (JNK) 1/2/3
and p38 isoforms α/ β/ γ (Erk 6) and δ (Krens et al., 2006; Kyriakis and Avruch, 2001;
Schaeffer and Weber, 1999). Drosophila expresses all three subgroups of the MAPK;
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Rolled (Rl), Basket (Bsk) and p38a/b. Rolled and Basket are Erk and JNK homologs,
respectively, whereas p38a/b are homologs of p38.EGFR signaling in Drosophila
The EGFR pathway in Drosophila begins with Spi binding to the extracellular domain
of DER. Ligand binding activates DER, which undergoes autophosphorylation and in turn
activates a downstream GTPase called Ras (Seger and Krebs, 1995). Activated Ras then
activates Raf1 (MAPKKK), which then phosphorylates and activates the dual specificity
kinase MEK (MAPKK). The kinase MEK then phosphorylates MAPK (ERK) at Tyr and Thr
residues within the activation loop (Zhang et al., 1995). Dual-phosphorylated MAPK
(dpERK) targets both cytoplasmic and nuclear proteins, phosphorylating at Ser/Thr/Tyr
residues (Reiser et al., 1999). In Drosophila, the nuclear targets of dpERK include ETS
transcription factors Pointed (Pnt) and Anterior open (Aop), also referred to as Yan (O'Neill
et al., 1994; Rebay and Rubin, 1995). Pnt, a transcriptional activator and Yan, a repressor,
both harbor an ETS-DNA binding domain, by virtue of which they compete for the regulatory
regions of the downstream transcriptional targets. Upon DER signaling, dpERK
phosphorylates Yan, which then undergoes nuclear export and subsequent degradation.
dpERK simultaneously phosphorylates Pnt converting it into a strong activator, which then
activates transcriptional targets previously repressed by Yan (Brunner et al., 1994; O'Neill et
al., 1994). This dual regulation thus confers bimodality of EGFR signaling in flies.
Negative regulators of the EGFR pathway also play a key role in fine-tuning the
complex signaling profile of this developmental pathway. In Drosophila, high level EGFR
activity upregulates transcription of the inhibitory ligand Aos (Golembo et al., 1996). Aos
inhibits EGFR signaling without directly interacting with the receptor. Instead, Aos binds to
the Spi, thus sequestering it. The Spi-Aos complex does not bind to the receptor and as
such a low steady state level of EGFR signaling is maintained in the cell (Klein et al., 2004).
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Role of EGFR in Drosophila eye and bristle development
From specification of the MF, to the specification of the different photoreceptors and
the their roles in ommatidial spacing, EGFR plays a critical role either working cooperatively
or antagonistically with Notch.
The EGFR pathway has been implicated in the initiation of the MF, upstream of Hh
and Dpp signals. It has been proposed that the EGFR pathway plays a role in both furrow
birth (formation of the posterior margin) and furrow reincarnation (formation of MF along the
lateral margin) during Drosophila eye development (Kumar and Moses, 2001). A study
conducted by Kumar and Moses suggests that during birth of the MF, the EGFR pathway
signals to Notch which in turn signals to Hh (Hedgehog). EGFR-mediated expression of Hh
induces photoreceptor differentiation, which, in turn, induces elevated EGFR signaling and
activation of the downstream effector Pnt. Activated Pnt confers regulation on Hh, thus
establishing a positive feedback loop which facilitates continued forward progression of the
MF (Rogers et al., 2005). During the furrow reincarnation step EGFR signals to Notch
which, in turn, activates the Dpp pathway (Kumar and Moses, 2001). Dpp is expressed
along the posterior and lateral margins of the developing retina, its ectopic expression leads
to the formation of precocious furrows along the anterior margins (Chanut and Heberlein,
1997).
It has been suggested that EGFR positively regulates expression of the homeo
domain protein Rough (ro) in the MF. Ro is expressed in the PNC, which induces Ato
expression in all but R8 cells, consequently selecting a single R8 cells. Thus EGFR
indirectly controls the singling out process of R8 cells by maintaining Ro expression in the
PNC (Dominguez et al., 1998).
The EGFR pathway plays an important role in machrochaete morphogenesis in
Drosophila, and accordingly hypomorphic mutations of the Egfr gene have been shown to
elicit the loss of several notum machrochaete with varying frequencies (Clifford and
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Schupbach, 1989). In mosaic clones of hypomorphic Egfr alleles, both the absence and the
duplications of macrochaetes have been observed (Diaz-Benjumea and Garcia-Bellido,
1990). The overexpression of the inhibitor of EGFR pathway, Aos, in the PNC results in the
loss of essentially all macrochaetes. It has been suggested that only a subset of bristles
require DER signaling. The notum machrochaetes, whose positions are invariant, are
sensitive to lowered dosage of DER signaling and fail to be specified in a precise manner,
the microchates are much more resistant to the lowering of the DER signaling (Culi et al.,
2001). This is perhaps an outcome of the invariant nature of the microchaetes, which are
organized in density patterns instead of being specified at fixed positions in the notum.
Suspected role of EGFR signaling during R8 specification in Drosophila
While there is abundance of evidence for the contribution of MAPK to retinal
determination, the role of the EGFR pathway in R8 selection is unclear. Analysis of the
EGFR allele Ellipse (Elp) revealed loss of intermediate group or R8 cells, suggesting a role
of Egfr in R8 specification (Lesokhin et al., 1999; Yang and Baker, 2001). Elp also
exacerbated the effects of the Notch allele, Nspl (Baker and Rubin, 1992), which by itself
exhibits a gain-of-function behavior affecting R8 selection. Moreover, ectopic activation of
EGFR pathway by several mechanisms was reported to enhance Ato expression and
specify ectopic R8s (Yang and Baker, 2001). It has also been suggested that the transient
expression of the dominant–negative EGFR, DERDN, blocks R8 specification and proneural
cluster formation. In addition, ectopic expression of Aos leads to the loss of Ato expression,
which, in turn, results in the loss of and aberrant spacing of R8s (Spencer et al., 1998).
Consistently, reducing Aos activity results in the formation of ectopic R8s, although
disruption of ommatidial patterning is not very severe in such a case (Freeman et al., 1992;
Spencer et al., 1998).
Investigators have detected dp-ERK, an active form of the MAPK, in the cytoplasm,
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several hours after EFGR activation (Kumar et al., 1998). This activated MAPK staining was
absent in EGFRnull clones, suggesting that dp-ERK accumulation is a direct downstream
effect of EGFR signaling and neither an artifact nor can be attributed to the activation of
other RTKs such as Sevenless (Lesokhin et al., 1999). The cytosolic hold on this kinase
would lead one to think that its established targets, the ETS family transcription factors Pnt
and Yan/Aop, are not the canonical targets of this pathway. Indeed if one looks at data from
the laboratory of Nicholas Baker, in clones of Pnt (Yang and Baker, 2003) there is no
evidence of defects in R8 spacing, suggesting that in this particular context the EGFR
pathway could well be used in a non-canonical manner, where the Egfr effects are not
realized within the nucleus. Based on these observations it has been suggested that EGFR
may cooperate with the Notch pathway to restrict R8 fate to a single cell within a PNC during
lateral inhibition.
Preface to chapters 2-4 of this dissertation
The studies described in Chapter 2 and 3 of this dissertation seek to address the
molecular mechanism of repression by M8 during R8 selection and patterning. These
studies should determine the contribution of EGFR/MAPK signaling in Ato repression by M8.
The proposed role of EGFR in R8 selection has heretofore lacked a molecular target. The
characterization of M8 as a mediator of EGFR pathway during R8 specification will address
this unresolved question.
In chapter 2, the studies described involve site-specific (Asp/Ala) variants of M8 to reveal
the role of CK2 and MAPK in repression of Ato. The findings, based on both gain- and lossof-function analyses, are consistent with the possibility that the two regulatory inputs, CK2
and MAPK, modulate Notch activity through sequential phosphorylation of the CtD of the
M8. Our studies indicate that both modifications of the Ser residues in the P-domain are
necessary to relieve the autoinhibited state of M8 and elicit its repressor activity during

34

neurogenesis. Moreover, studies using spatially controlled expression of M8 variants
suggest that CK2 is likely to play a more permissive role, whereas MAPK controls when and
where M8 is activated. Such a control mechanism through two kinases may control both the
amplitude and duration of active M8 within the MF.
In chapter 3, I more directly evaluate the role of the P-domain in autoinhibition. I have
generated deletion constructs, which either lack the CK2 motif, or the MAPK motif or the
entire P-domain. The experiments described in this chapter of the dissertation address the
important question whether CK2 and MAPK phosphorylation are required purely (solely) at
the level of intramolecular protein contact(s) and whether dual modification of these two
sites are necessary to restrain repression by M8.
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Fig. 1: Core components of Notch pathway and Drosophila Notch Receptor.
(A) The core components of Notch pathway as seen in different species. (B) Schematic
representation of the domain organizations in Drosophila Notch receptor.
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Fig. 2: Schematic representation of Notch signaling pathway.
The primary steps in Notch activation involve glycosylation and cleavage by Furin (S1
cleavage) followed by receptor maturation. When ligand binds to the Notch receptor of an
adjacent cell, the receptor undergoes two consecutive proteolytic cleavages, releasing
NICD, which translocates to the nucleus and mediates transcription of the E(spl)/HES
genes.

37

Fig. 3: Lateral inhibition during R8 specification in Drosophila eye development.
Notch signaling plays a role in lateral inhibition, as seen between adjacent cells in the
proneural cluster (PNC). This inhibitory signal is contact-dependent and is mediated by the
ligand Delta, which appears on the cell surface of one cell and binds to the Notch proteins
on the neighboring cells. The future R8 cell (orange) is shown to express high levels of
Delta, which binds to the Notch receptor in the adjacent non-R8 cell (white) and triggers
inhibitory Notch signaling. The pathway terminates with expression of E(spl) repressors
(here M8 is indicated) that along with co-repressor Groucho antagonizes proneural protein
Atonal.
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Fig. 4: Compound eye of Drosophila and mechanism of R8 specification and
patterning.
SEM shows the structure of the adult compound eye in Drosophila, which is an array of
precisely positioned cluster of unit eyes known as the ommatidium. (A) The bold arrow
indicates the progression of the morphogenetic furrow (MF, blue vertical stripe) from the
posterior to the anterior part of eye disc. (B) Eye disc showing the expression pattern of the
proneural protein Atonal, which is expressed in a broad stripe ahead of the MF, but
posteriorly resolves into single cells that become R8’s. (C) A schematic representation of
the MF showing the biphasic role of Notch during R8 specification. Inset below represents
the sequential recruitment of the secondary photoreceptors following R8 specification.
(Panels A and B adapted from (Frankfort and Mardon, 2002))
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Fig. 5: Bristle morphogenesis in Drosophila.
(A) The position of the Macrochaetes (MCs - yellow asterisk) and the microchaetes (mcs –
black arrow) on the nota of the fly body. (B) Position of the interommatidial bristles (IOBs –
yellow asterisk) on the eye of fruit fly. (C) Bristle morphogenesis requires Notch mediated
lateral inhibition during SOP selection followed by asymmetric division of the SOP for
lineage specification. Inset shows the four different cell types that constitute the structure of
a bristle.
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Fig. 6: E(spl) C locus and its molecular synteny across 12 Drosophila species.
(A) Schematic representation of the genomic organization of E(spl) locus. It encodes for
seven E(spl) repressors and the co-repressor Groucho. E(spl)- mδ, mγ and m8 are
expressed in the MF (green boxes). Proteins encoded by E(spl)- mγ, m5, m7 and m8 have
conserved CK2 sites (highlighted in red). (B) Molecular synteny of E(spl) locus across 12
Drosophila species. Note (red arrow pointing at centromere) that there is a complete
inversion of the locus for six Drosophila species, although the order of the transcription units
remains intact (adapted from Majot et al., 2015)).
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Fig. 7: Structure of M8 and autoinhibition model of M8 regulation.
(A) Schematic representation of the functional domains of E(spl)M8. Conserved Ser
residues in the phosphorylation domain (P-domain) of the CtD in M8, M5, M7 and human
and murine HES6 proteins. The yellow boxes represent the MAPK and CK2 motifs.
Additional conserved Ser residues are also highlighted (red). (B) Autoinhibition via CtD
may block dimerization via HLH (blue) or Ato binding via Orange domain. Phosphorylation
of M8 by CK2 regulates antagonism of Ato/ASC in N+ flies, whereas M8* requires Nspl
background (adapted from(Kahali et al., 2010b))
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Fig. 8: Structure of CK2 holoenzyme and the alleles of Drosophila CK2α subunit.
(A) Schematic representation of the CK2 holoenzyme. It is a tetramer made up of α
(catalytic) and β (regulatory) subunits. Ribbon diagram of the human CK2 holoenzyme (as
described in (Niefind et al., 2001)). The two catalytic subunits (magenta) assemble on the
two regulatory (yellow and blue) subunits. (B) The three alleles of Drosophila CK2α subunit
– CK2MB0047, Tik and TikR and their corresponding lesions are indicated.
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Fig. 9: Components of the Drosophila EGFR pathway.
Ligand binding activates EGFR receptor on the cell surface, which undergoes
autophosphorylation and activates downstream effector molecules. The downstream
signaling cascade activates MAPK, which translocates to nucleus and phosphorylates
Pointed (Pnt) and Yan.
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CHAPTER 2: The conserved MAPK site in the Notch effector E(spl) M8 controls
repressor activity in the eye
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Abstract
Enhancer of split (E(spl)) M8, an effector of Drosophila Notch signaling, is activated
by protein kinase CK2 and inhibited by the phosphatase PP2A. CK2 targets a region of M8
that conserves additional Ser residues. One of these Ser residues meets the strict
consensus for MAPK, a kinase that mediates the effects of Epidermal Growth Factor
Receptor (EGFR) signaling. The studies described here reveal an important role for the
conserved MAPK site on M8. Our analysis, using Ala/Asp mutations, suggests that together
CK2 and MAPK ensure that M8 repression of Ato occurs in a timely manner and at a precise
stage (stage-2/3) of R8 birth. M8 repression of Ato is mitigated by halved EGFR dosage,
and this effect requires an intact MAPK site. Accordingly, variants of M8 with a
phosphomimetic Asp at the MAPK site exhibit earlier (inappropriate) activity against Ato at
stage-1, where a positive feedback-loop is needed to raise Ato levels to a threshold
sufficient to specify the R8 fate. Using deletion variants, we demonstrate that both kinase
sites likely contribute to ‘cis’-inhibition of M8. This key regulation by CK2 and MAPK is
bypassed by the E(spl)D mutation encoding the truncated protein M8*, which inhibits Ato at
stage-1 of R8 birth. Finally, we provide evidence that PP2A likely targets the MAPK site,
and that regulation of M8 by MAPK appears to be dispensable during bristle development.
Together, our studies reveal that multi-site phosphorylation controls timely onset of M8
repressor activity in the eye, but does not appear to play a role in the bristle. The high
conservation of the CK2 and MAPK sites in the insect E(spl) proteins M7, M5 and Mγ, and
their mammalian homologue HES6, suggest that this regulation may enable E(spl)/HES
proteins to orchestrate repression by distinct tissue-specific mechanisms, and is likely to
have broader applicability than previously recognized.
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Introduction
The external sensory organs of Drosophila include the compound eye and the
mechanosensory bristles which are patterned and established during the larval and pupal
stages of development. The remarkably precise hexagonal geometry of the compound eye
of fruit flies has afforded an ideal system to understand pattern formation during
development. The compound eye of Drosophila is composed of ~800 light sensing
repetitive units (ommatidia) arranged in a hexagonal lattice. Each ommatidium is composed
of eight photoreceptors (R1-R8), twelve accessory cells and an interommatidial bristle (IOB).
During the third larval stage (instar), eye morphogenesis initiates at the posterior
margin of the eye disc, a monolayer neuro-epithelium that is the progenitor of the retina.
Retinal neurogenesis starts with the specification of the R8 photoreceptors in a moving
wave of differentiation, called the morphogenetic furrow (MF) (Jarman et al., 1994). While
R8 selection occurs within the MF, all secondary photoreceptor recruitment occurs posterior
to it (Wolff and Ready, 1991). The temporal nature of the MF thus represents a 48-hour
window, encompassing retinal neurogenesis.
R8 specification occurs in the MF and involves biphasic Notch signaling. At stage-1,
the leading edge of the MF, Notch induces the expression of the proneural bHLH activator
Atonal (Ato) at a low level to form the ‘Ato-stripe’. Heterodimers of Ato and Daughterless
(Da) then elicit high levels of ato transcription. This process, called ato auto-activation,
generates neural competency in a group of equipotent cells termed proneural clusters
(PNCs). At stage-2/3 of the MF, the future R8s of the PNC express high level of ligand
Delta (Dl), which interact with the Notch (N) receptors of the adjacent cells (Simpson, 1990).
Activated N receptors undergo cleavage and release the intracellular domain (Nicd), which
then translocate to the nucleus. In the nucleus, Nicd interacts with Suppressor of Hairless
(Su(H)) and elicits transcription of bHLH repressors encoded by the Enhancer of split
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Complex (Eslp(C) (Bailey and Posakony, 1995; Delidakis and Artavanis-Tsakonas, 1991;
Lecourtois and Schweisguth, 1995). The E(spl) proteins, in a complex with Gro, refines Ato
expression to a single cell of the PNC (Ligoxygakis et al., 1998; Paroush et al., 1994). This
phase of inhibitory Notch signaling where R8 cell fate is restricted to one cell in the precluster is known as ‘lateral inhibition’. By stage-4, single patterned R8s emerge and
differentiate as the R8 photoreceptors by sustaining expression of the Ato target gene
senseless (sens). The R8s then systematically recruit surrounding uncommitted cells as the
R2/R5, R3/R4, R1/R6 cells, concluding with the specification of the R7 cell (Cagan and
Ready, 1989).
Given that lateral inhibition is critical for proper structure and patterning of the eye
and E(spl) proteins are central to this process, several genetic studies have sought to
analyze their modes of action (Giebel and Campos-Ortega, 1997; Knust et al., 1987; Nakao
and Campos-Ortega, 1996; Preiss et al., 1988; Ziemer et al., 1988). Although these studies
were the first of their kind to establish the role of E(spl) proteins in eye patterning, it has
been difficult to identify their exact roles because Eslp(C) encodes seven bHLH proteins
with similar functional domains. To complicate things further, individual mutations affecting
each transcriptional unit have been unavailable, making it impossible to study their individual
effects on pattern formation. Initial studies revealed that over-expression of any E(spl)
protein elicited loss of bristles and the SOPs (Giebel and Campos-Ortega, 1997; Nakao and
Campos-Ortega, 1996). Consequently, these proteins have been considered to be
functionally redundant (Cooper et al., 2000), a view that also extends to their mammalian
homologues, the HES proteins. It has been argued that 'redundancy' is an
oversimplification, as the order of the seven E(spl) genes and their direction of transcription
is conserved over ~60 myr of Drosophila evolution (Maier et al., 1993).
Three E(spl) members, M8, Mγ, Mδ, are expressed in the eye tissue during R8
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selection but only ectopic Mδ elicited loss of R8s (Ligoxygakis et al., 1998). It therefore,
raises the possibility that these three E(spl) members are ‘qualitatively different’, but the
underlying nature of this difference remained unresolved.
The central role of M8 during R8 selection is underlined by the R8 and eye defects of
the unique dominant allele E(spl)D (Welshons, 1956). In the presence of a gain of function
Notch allele, Nspl, the E(spl)D allele disrupts retinal histogenesis. It is this interaction that led
to the original identification of the E(spl) locus. E(spl)D encodes a truncated protein called
M8*, which lacks 56 C-terminal residues (CtD) (Nagel et al., 1999; Tietze et al., 1992). It
was observed that ectopic M8*, but not full length M8, mimics the R8 defects of E(spl)D,
indicating that the truncation results in a hyperactive protein. The hyperactivity of M8*
indicated that the CtD region is likely to regulate repressor activity of M8. Studies in our
laboratory, identifying the phosphorylation of M8 at its CtD by protein kinase CK2 provided
key insights into the mechanisms underlying hyperactivity of M8* and thus regulation of
repression by M8 (Trott et al., 2001).
CK2 phosphorylates M8 at Ser159 in the CtD. Replacement of the CK2 phosphoacceptor (Ser159) with a phosphomimetic Asp residue (M8-S159D) was found to elicit
exacerbated loss of R8s and the eye with a potency akin to E(spl)D (Kahali et al., 2009a;
Karandikar et al., 2004; Nagel et al., 1999). Moreover, M8-S159D interacts with Ato with a
binding strength equal to that of M8*. Consequently it was proposed that the CtD
autoinhibits full length M8 (Kahali et al., 2010a). Phosphorylation displaces this intramolecular interaction permitting repression of Ato. The truncation of M8* would bypass this
regulation, implicating CK2 as a regulator of R8 selection through the activation of M8
(Karandikar et al., 2004). Accordingly, loss of CK2 in the imaginal disc of an otherwise wild
type flies compromises lateral inhibition and elicits the specification of excess R8s from the
IGs (Bose et al., 2006).
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The eye defects of the CK2-mimic M8-S159D are specific to stage-2/3 of the MF. If
CK2 were to solely control auto-inhibition, the expression of M8-S159D at stage-1, where
Ato levels are the lowest, should have also elicited loss of R8 and the eye. The inactivity of
M8-S159D at stage-1 raises the possibility that CK2 may be insufficient to activate M8. If so,
are other regulatory enzymes involved? This possibility is likely given that the CK2 site in
M8 is located in a region termed the P-domain that conserves a number of other Ser
residues. The P-domain is conserved in all M8 isoforms through ~60 million years of
Drosophila evolution. The Ser residues represent consensus motifs for phosphorylation by
MAPK, CK1 and GSK3. The high conservation of Ser residues, in addition to those
modified by CK2, raises the possibility that M8 may be regulated by multisite
phosphorylation. Although no R8 defects have been described for mutations in CK1 and
GSK3, numerous lines of evidence implicate EGFR signaling in R8 selection. This pathway
is also known as the Drosophila EGF receptor or DER pathway in Drosophila.
Studies from several groups have shown the presence of active MAPK
(diphosphorylated ERK) in IG cells at stage-2/3 of the MF (Kumar et al., 2003; Kumar et al.,
1998; Spencer et al., 1998; Yang and Baker, 2003); this staining is lost in the clones of
EGFR (Lesokhin et al., 1999) demonstrating that other RTKs such as Sevenless, are not
responsible for activating MAPK. Moreover, in DER clones the IGs do not resolve into
single R8 and excess R8s are specified (Baonza et al., 2001). An identical effect is seen in
eye disc lacking the downstream effectors of the DER pathway, i.e., Ras and Raf (Yang and
Baker, 2001). In the canonical DER pathway, activated MAPK targets the nuclear
transcription factors Pointed (Pnt) and Yan. Surprisingly, unlike DER clones, extra R8s are
not seen in clones lacking pointed (Yang and Baker, 2003). In addition, activated MAPK in
the IGs is held in the cytosol (Kumar et al., 2003), a location that should prevent its targeting
of nuclear-only Pnt or Yan (Shilo, 2003). The possibility remains that the role of DER/MAPK
is to target and activate M8 allowing for repression of Ato. In a sense, DER may therefore
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control when and where M8 activity manifests.
The studies we describe here indicate the importance of MAPK motif in M8 repressor
activity. Site-specific as well as deletion mutants of CK2 and MAPK sites of M8 have been
used to demonstrate the role of these two kinase motifs during R8 specification. Our studies
indicate that modifications at both sites appear to be necessary for M8 repressor activity and
modification at the CK2 site is epistatic to phosphorylation at the MAPK site. If M8 activity
were to require both CK2+MAPK, it would establish that EGFR signaling potentiates Notch
pathway activity; that these two signaling pathways do not always act in an antagonistic
manner, and provide a molecular target for activated MAPK in IG cells.

Results
M8 repressor activity in the developing eye requires multi-site phosphorylation
The birth of patterned R8s in the MF (Fig. 1A) hinges upon timely repression of Ato
by E(spl) proteins. The importance of E(spl)-M8 is supported by the severely reduced eye of
the m8 mutation E(spl)D (encoding M8*) and that of a variant (M8-S159D) harboring Asp in
place of Ser159, the target for protein kinase CK2 (Fig. 1B). The latter studies, which
utilized Gal4 drivers with expression at distinct stages of R8 ontogeny (Fig. 1A), reveal that
phosphorylation of Ser159 is key to Ato repression (Fig. 1B) (Karandikar et al., 2004). The
reduced eye of M8-S159D is seen with scaGal4 and 109-68Gal4, whose stage-2/3
expressivity (Fig. 1A) correlates to endogenous E(spl) genes. The difference in severity of
the reduced eye (Fig. 1B) reflects stronger strength of scaGal4, as compared to 109-68Gal4
(Doherty et al., 1997). No reduced eye is seen with wild type M8 (Fig. 1B), a finding
previously shown by others (Giebel and Campos-Ortega, 1997; Nagel et al., 1999). It was
proposed that CK2 converts ‘cis’-inhibited M8 to a state active for binding and repressing
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Ato. This regulation is bypassed by the Asp at the CK2 site (M8-S159D), or upon loss of the
CtD and the P-domain in M8*, the product of E(spl)D (see schematic in Fig. 1B).
Follow-up studies suggest that activation of M8 by CK2 is an oversimplification.
First, unlike its reduced eye at stage-2/3, expression of M8-S159D at stage-1 (hH10Gal4) is
without effect (Fig. 1B). This stage-1 inactivity was unexpected as Ato levels are lowest at
this point of R8 birth (Fig. 1A), and should have been most sensitive to repression by (non
‘cis’-inhibited) M8-S159D. This inactivity does not reflect weak strength of hH10Gal4, as
expression of M8* with this Gal4-driver elicits a near complete loss of the eye (Fig. 1B, and
see refs). Second, we have recently reported that the reduced eye of M8-S159D is strongly
mitigated by increased activity of the phosphatase PP2A (Bose et al., 2014). Because
replacement of Ser159 with Asp should have rendered M8 refractory to phosphatase
activity, we hypothesized that multi-site phosphorylation of the P-domain (Fig. 1B) controls
M8 repression of Ato.
To analyze multi-site phosphorylation of M8, we adopted site-specific (ϕC31)
integration to enable controlled comparisons of Ala/Asp variants at multiple kinase sites.
We chose the ϕC31 site at 68E, one of ‘moderate’ expressivity. This site was chosen,
because random insertions of M8-S159D elicit a near complete loss of the eye (Fig. 1B),
which we reasoned is likely to be a limit phenotype and thus unlikely to reveal the
contributions of phosphorylation of sites in addition to CK2. Accordingly, scaGal4
expression of M8-S159D (from ϕC31-68E) elicits a reduced eye of moderate severity (Fig.
1C, E). No eye defect is seen upon expression of M8-S159D with hH10Gal4, or in relevant
controls (Fig. 1D, E). Thus the M8-S159D insertion at ϕC31-68E qualitatively mimics
random insertions, described previously.
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E(spl)-M8 harbors a highly conserved consensus site for MAPK
The P-domain of M8 contains four Ser residues, which are invariant in 12 Drosophila
species and the stalk-eyed fly Teleopsis (Fig. 2A) that diverged ~100 MYA. The flanking
Ser residues meet the strict consensus for CK2 and MAPK, and the intervening six residues
contain two additional phosphoacceptors. Importantly, the CK2 and MAPK sites are
conserved in mammalian HES6, but with three distinctions. First, an insertion of six
additional residues widens the spacing of the CK2 and MAPK sites. Second, this insertion
includes tandem Asp residues (DD motif, Fig. 2A), which can often bypass the need for
phosphorylation. Third, mouse HES6 replaces a Ser with Pro in the linker, suggesting that
this site may not be vital to regulation of human HES6.
The full analysis of the contributions of all four Ser residues of M8 with Ala and/or
Asp would necessitate ≥64 variants, beyond the scope of a single manuscript. We focused
on the MAPK site, as this protein kinase mediates the effects of EGFR signaling, a pathway
implicated in the birth of patterned R8s, and because murine HES6 is modified by CK2 and
MAPK (Belanger-Jasmin et al., 2007; Gratton et al., 2003b). The developmental roles of
HES6 phosphorylation remain unknown. Given the divergence time between Dipterans and
mammals (Fig. 2A), we hypothesized that MAPK is important in controlling M8 activity.
We previously reported that a variant refractory for CK2 (M8-S159A) does not mimic
wild type (unmodified) M8, but elicits a rough eye due to dominant-negative (DN) activity
(Karandikar et al., 2004). We thus refrained from mutating the MAPK site on a backbone
with an Ala at the CK2 site. A backbone of wild type M8 or M8-S159D (Fig. 2B) was used to
generate three Ala/Asp variants of Ser151, the MAPK site. M8-S151A+S159D is refractory
to MAPK but mimics CK2, and should reveal if these two kinases cooperate to control M8
activity or act redundantly. M8-S151D is a MAPK-mimic that should render M8 activity
independent of EGFR/MAPK signaling. The third, M8-S151D+S159D, is a dual kinase
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mimic that should render M8 activity independent of CK2 and MAPK. In a yeast two-hybrid
assay, all variants interact robustly with Groucho (Gro, Fig. 2B), which is essential for M8
repressor activity in vivo.
An intact MAPK site is essential for activity of the CK2 mimic M8-S159D
We first compared the activity of M8-S159D (CK2 mimic) and M8-S151A+S159D
(refractory to MAPK but mimics CK2). Unlike M8-S159D, no reduced eye was seen upon
expression of M8-S151A+S159D with scaGal4 (compare Fig. 3A to Fig. 1C). Two findings
argue against a defective construct or instability of M8-S151A+S159D protein in vivo. This
variant inhibits development of the IOBs (data not shown) and strongly elicits the loss of
macrochaetes (MC’s) and microchaetes (mc’s) with potency similar to the CK2 mimic M8S159D (Fig. 3B, C). These effects on the MC’s/mc’s reflect expression of scaGal4 in
proneural clusters that give rise to these bristle types. Thus an intact MAPK site is essential
for M8 repressor activity in the eye, but not the bristle.
We next tested the MAPK-mimic (M8-S151D) and the dual-kinase mimic (M8S151D+S159D). However, both variants elicited embryonic lethality when expressed with
scaGal4. Lethality was seen even in crosses conducted at 18C where Gal4 activity is often
attenuated (Fig. 3D). To circumvent this problem, we used 109-68Gal4, a weaker stage-2/3
driver. Flies expressing all four M8 variants were viable and elicited a range of eye defects.
Expression of the CK2 mimic (M8-S159D) elicited a rough eye and loss of the IOBs (Fig.
4A), but did not significantly reduce eye size (compare to Fig. 1C). This lack of a reduced
eye reflects moderate expressivity from the ϕC31-68E site (Fig. 1B, C) combined with the
weaker driver 109-68Gal4. The rough eye of M8-S159D was abrogated by the introduction
of an Ala at the MAPK site (Fig. 4D), although loss of IOBs remained (data not shown). In
contrast, the MAPK-mimic (M8-S151D) or the dual-kinase mimic (M8-S151D+S159D)
elicited a strong loss of the eye with almost equal severity (Fig. 4B, C) demonstrating the
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importance of the MAPK site in controlling M8 activity. No eye/IOB defects are seen in 10968Gal4/+ flies or the four M8-transgenic lines on their own (inset in Fig. 4E). As 109-68Gal4
is active in PNCs that give rise to bristles, we also quantified loss of the MCs. Although
attenuated in severity when compared to results with scaGal4 (Fig. 3B, C), expression of all
four variants with 109-68Gal4 elicited MC loss with similar potency (Fig. 4A’, B’, C’, D’). The
lack of effects on the mcs reflects weaker strength of 109-68Gal4. Together, these studies
reveal that the MAPK site is important for M8 activity in the eye, but not the bristle.
M8 variants with a modified MAPK site perturb R8 specification
We next determined if M8 variants perturb birth of R8s and secondary
photoreceptors by staining for Senseless (Sens) and ELAV, respectively. The reduced eye
upon expression of the CK2-mimic M8-S159D with scaGal4 (Fig. 1C) reflects strong loss of
R8s (Sens+ cells), and many of the R8s that emerge from the MF poorly sustain Sens
expression, and thus inefficiently recruit secondary (ELAV+) photoreceptors (for example
see Fig. 7A’).
As the expression of MAPK variants with scaGal4 was lethal (Fig. 3D), we used 10968Gal4 to enable analysis of all M8 variants. Consistent with the wild type eye, 10968Gal4/+ flies display proper Sens expression/maintenance and ELAV staining akin to wild
type discs (data not shown). Expression of the CK2 mimic M8-S159D elicited the weakest
effects (Fig. 5A) wherein a few R8s failed to maintain Sens expression and poorly recruited
ELAV+ cells. Consequently, a few regions of the eye disc are devoid of closely juxtaposed
ELAV clusters (circled region in Fig. 5A’), as compared to control discs. These R8s are
likely removed by apoptosis, a default fate for uncommitted cells, contributing to the ‘rough
eye’ of M8-S159D expressing flies (Fig. 4A). No such defects are seen with M8S151A+S159D (Fig. 5B,B’), confirming that an Ala residue at the MAPK site renders M8
inactive in the eye even in the presence of an activating mutation at the CK2 site. In
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contrast, discs expressing the MAPK mimic M8-S151D or the dual-kinase mimic M8S151D+S159D display the inconsistent maintenance of Sens levels along the AP axis in a
greater proportion of R8s (Fig 5C, D). Many of these R8s also poorly recruit secondary
photoreceptors, such that numerous clusters contain less than (the normal) 1Sens+7ELAV
cells, characteristic of discs from 109-68Gal4/+ or wild type flies (Fig. 5C’,D’). Moreover,
significant regions of the eye disc altogether lack Sens+Elav clusters, a result consistent
with the reduced eye. Thus the reduced eyes of the variants described in Fig. 4 reflect
defective birth and survival of R8s, which consequently impairs secondary photoreceptor
recruitment.
An Asp residue at the MAPK site elicits inappropriate earlier activity of M8
We next tested if an Asp at the MAPK site renders M8 prematurely active, i.e., at
stage-1 of the MF. This test was conducted because M8* (lacking the ‘cis’-inhibitory CtD)
elicits a strong loss of the eye at stage-1, whereas the CK2 mimic M8-S159D is without
effect (Fig. 1B, D). As (endogenous) MAPK is normally activated at stage-2/3 of the MF
where R8s are selected by lateral inhibition, we reasoned that an Asp at the MAPK site
might well bypass the need for EGFR/MAPK signaling, and exhibit premature activity at
stage-1, in a manner akin to M8*.
Indeed, the MAPK-mimic (M8-S151D) and the dual-kinase mimic (M8S151D+S159D) both elicit a reduced eye upon expression at stage-1 (with hH10Gal4) with
similar potency (Fig 6A, B), and perturb the ommatidial lattice and the position of the IOBs
(Fig. 6A’, B’). No reduced eye was observed with M8-S151A+S159D (mimics CK2, but not
MAPK), and neither did this variant elicit defects in the ommatidial lattice or the position of
the IOBs (Fig. 6C, C’). These data seem consistent with the possibility that both CK2 and
MAPK are needed for proper activation of M8 in a timely manner at stage-2/3; this
regulatory system is bypassed by Asp mutations or by deletion of the CtD.
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Altered EGFR signaling modulates M8 variants with an intact MAPK site
Given the importance of the MAPK site for M8 activation, we directly tested for a role
for EGFR signaling. We used egfrf24, a loss of function allele, which does not perturb the
eye/R8s in the heterozygous state (data not shown) but is lethal when homozygous. We
reasoned that if EGFR/MAPK signaling activates M8, then halved EGFR levels should
attenuate the amount of active MAPK, and result in diminished phosphorylation of M8. If so,
M8-S159D (mimics CK2 but an intact MAPK site) should become hypo-phosphorylated in
egfrf24/+ flies, thereby dampening the severity of its reduced eye. In contrast, the MAPKmimic (M8-S151D) and the dual-kinase mimic (M8-S151D+S159D) should be refractory to
halved EGFR signaling by virtue of the Asp residue at the MAPK site.
Both of the suggested predictions bear out. The CK2 mimic M8-S159D was
expressed with scaGal4, given the significant effect on the eye with this stage-2/3 driver.
Compared to its effects in an egfr+ background (Fig. 7A), the severity of the reduced eye of
M8-S159D is significantly attenuated in egfrf24/+ flies (Fig. 7B), a result supported by
quantitative analysis of eye size (Fig. 7C). Staining of eye discs reveals the cell specificity
underlying the restoration of eye size in the egfrf24/+ background. Expression of the CK2
mimic M8-S159D in egfr+ flies (Fig. 7A’) elicits strong loss of patterned R8s (Sens+ cells),
impairs R8 survival (maintenance of Sens levels) and results in diminished recruitment of
secondary photoreceptors (ELAV+ cells). These R8 defects are strongly suppressed in an
egfrf24/+ background (Fig. 7B’ and B”).
A similar analysis was conducted with the MAPK-mimic (M8-S151D) and the dual
kinase mimic (M8-S151D+S159D), but utilized the driver 109-68Gal4 due to lethality upon
expression with scaGal4 (see Fig. 3D). With both of these variants the severity of the
reduced eye was indistinguishable in egfr+ versus egfrf24/+ backgrounds, qualitatively
(compare Fig. 7D, E to Fig. 4B, C) as well as quantitatively (Fig. 7F, graph includes values
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from Fig. 3E). Staining of eye discs revealed that these two variants elicit R8 defects
indistinguishable from those described earlier in egfr+ flies (Fig. 5, and data not shown).
Thus eye/R8 defects of M8 variants with a phosphomimetic Asp at the MAPK site are
insensitive to halved EGFR/MAPK signaling.
Deletion of the CK2 or MAPK site mimics Asp-variants of M8 at these two kinase sites
We next sought to test the contributions of the CK2 and MAPK sites to ‘cis-inhibition’.
We were intrigued by the findings that the MAPK-mimic M8-S151D or dual-kinase mimic
M8-S151D+S159D both elicited a reduced eye and R8 defects at stage-1 of the MF (Fig. 6)
in a manner akin to non-inhibited and constitutively active M8* (see Fig. 1B). These studies
did not, however, resolve if the MAPK site in conjunction with CK2 imposes cis-inhibition on
M8, or if the similar stage specificity of the MAPK-mimic and M8* is purely incidental.
Specifically, we sought to determine if modification by CK2+MAPK serves primarily as a
conformational switch, rather than for binding of repressive cofactors (other than Gro) to the
phosphorylated CtD of M8. For this, we asked if deletion of the CK2 or MAPK site renders
M8 active, thereby mimicking the outcomes of Asp mutations at these kinase sites. We
deleted just the consensus sites for these two kinases. The first, M8-ΔCK2 lacks the CK2
site S159DCD, whereas the second M8-ΔMAPK lacks the MAPK site PLS151P (Fig. 8A).
Based on the ‘cis’-inhibition model and studies with Asp mutations at the CK2 and/or
MAPK sites (Figs. 1, 3-7), we made three predictions. First, M8-ΔCK2 should resemble the
CK2-mimic M8-S159D and elicit a reduced eye at stage-2/3, but not stage-1. Second, M8ΔMAPK should mimic M8-S151D and elicit a reduced eye at stage-1 and stage-2/3. Third,
the reduced eye of M8-ΔCK2 should be mitigated by halved egfr dosage, whereas that of
M8-ΔMAPK should be insensitive.
Indeed, all three predictions bear out (Fig. 8). At stage-1, M8-ΔCK2 is largely
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inactive, whereas M8-ΔMAPK elicits a ~50% reduction of the eye (Fig. 8B, C, D). In
contrast, M8-ΔCK2 elicits a strong loss of the eye at stage-2/3 (Fig. 8E), whose severity is
significantly attenuated in an egfrf24/+ background (Fig. 8F). This result is supported by
quantitative analysis of eye size (Fig. 8G). As predicted, expression of M8-ΔMAPK at stage2/3 elicits a reduced eye of comparable size in egfr+ or egfrf24/+ backgrounds (Fig. 8H, I),
results also supported by quantitative analysis of eye size (Fig. 8J). Thus deletion of the
CK2 and MAPK sites elicits M8 activity and eye defects that closely mimic the effects of Asp
mutations at these respective kinase sites. We conclude that the two flanking kinase sites
participate in ‘cis’-inhibition of M8, and that this control is bypassed by deleting kinase
consensus sites within the P-domain (Fig. 8), the introduction of phospho-mimetic Asp
residues or by the complete loss of the CtD, as with M8* (Fig. 1B).
PP2A may target the MAPK site during M8 regulation
Recent studies from our lab reveal a role for the phosphatase PP2A in birth of
patterned R8s (Bose et al., 2014). Relevant to the studies described here, overexpression
of widerborst (wdb), a PP2A regulatory subunit, rescues the eye /R8 defects of the CK2
mimic M8-S159D (Fig. 9A). No rescue was evidenced upon co-expression of UAS-LacZ,
excluding the possibility that rescue reflects competition between two UAS-constructs for a
limiting amount of Gal4 protein. The modulation of the eye defects of M8-S159D by wdb
raised the prospect that PP2A targets the MAPK site, rather than that for CK2.
We thus tested if PP2A opposes the effects of EGFR/MAPK signaling, by asking
whether co-expression of UAS-Wdb modulates the reduced eye of the MAPK-mimic (M8S151D) and the dual-kinase mimic (M8-S151D+S159D). The reduced eye of either variant
upon co-expression of UAS-Wdb (Fig. 9B, C) appeared similar to that in its absence (Fig.
compare with Fig. 4B, C), a result supported by quantitative analysis of eye size (Fig. 9D).
The eye sizes in the presence of ectopic Wdb were statistically similar to those in its
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absence (note that Fig. 9D includes data values from Fig. 4). Hence, unlike the CK2-mimic
M8-S159D, an Asp residue at the MAPK site renders M8 insensitive to Wdb, suggesting that
this phosphatase might oppose M8 activation by EGFR/MAPK signaling. In summary, we
conclude that the highly conserved MAPK site is important for activation of M8 in a spatially
precise manner in the MF, and that this activation is antagonized by PP2A.
Discussion
The studies described here reveal that the highly conserved MAPK site in M8 is
important for repressor activity in the developing eye, but appears to be dispensable during
bristle development. Specifically, our studies have utilized Ala/Asp variants of the MAPK
site in wild type (Figs. 1, 3, 4, 5, 6) and egfr mutant backgrounds (Fig. 7). These findings
support an important role for EGFR/MAPK signaling in controlling M8 repression of Ato. In
addition, our studies on deletion variants of M8 (Fig. 8) reveal that both kinase consensus
sites contribute to ‘cis’-inhibition, which is regulated by multi-site phosphorylation. Finally,
our analysis of PP2A-Wdb (Fig. 9) raises the prospect that this phosphatase targets the
MAPK site of M8. The conservation of sites for these two kinases in M7, M5 and Mγ raises
the prospect that this regulatory mechanism has a broader impact that has been realized.
Together, our studies reveal that instead of acting merely in a dosage-dependent manner,
distinct tissue-specific regulatory mechanisms control repression by E(spl) proteins.
Multi-site phosphorylation exerts spatial control over M8 activation in the eye
The studies we describe here expand on our understanding of the role of the
conserved P-domain in M8. Our data suggest a revised model wherein conversion of the
‘cis’-inhibited state of M8 to an active repressor of Ato depends upon phosphorylation of the
CK2 and MAPK sites, and that the precise (restricted) activation of this key Ato repressor at
stage-2/3 of the MF occurs in response to EGFR signaling (Fig. 10). If so, it would suggest
that EGFR signaling, which is required to activate MAPK at stage-2/3, is crucial for inhibitory
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effects of Notch to occur properly, and without which R8 patterning and eye development
would be perturbed. The emerging role for PP2A in regulation of M8 activity raises the
prospect that this phosphatase may play two potential roles, not necessarily mutually
exclusive. By antagonizing modification at the MAPK site, PP2A may control the amount of
active (non ‘cis’-inhibited) M8, or it may act to control M8 inactivation immediately upon the
selection of single R8s. The former regulation may thus impose control over ‘signal
amplitude’ (amount of active M8), whereas the latter would control ‘signal duration'. Our
studies, which do not discriminate between these possibilities, nevertheless reveal that
repression by E(spl)-M8 is controlled by PTM.
We note that our analyses do not reveal the epistatic relationship between CK2 and
MAPK, because demonstration of the order of M8 phosphorylation necessitates isoformand phospho-specific antibodies. Our efforts to raise antibodies that recognize specific
phosphorylated forms of M8s CtD have not been successful, as they display cross-reactivity
not only with unmodified M8 but with other members that share sequence similarity in their
CtDs (M5, M7, Mγ). In light of the close conservation of the CK2 and MAPK sites in the
E(spl) proteins M7, M5 and Mγ, the likelihood is high that this manner of regulation may
have a broader impact in tissues where these bHLH proteins function. We discuss the
implications of our findings in the context of two signaling pathways, Notch and EGFR,
which are vital not only to R8 ontogeny, but also to subsequent stages of retinal
histogenesis.
Notch and the specification of the R8 cells
The key role of Notch as the driver for lateral inhibition is indisputable. Detailed and
elegant studies have shown that loss of Su(H) or the E(spl)C leads to the specification of
excess (‘twinned’) R8s, a hallmark of impaired lateral inhibition. The developmental
outcome of loss of Notch is more complicated, in particular at the onset of retinal
61

histogenesis because this receptor plays dual roles during birth of the R8 cells. Notch is first
needed for ‘proneural enhancement’, a positive feedback loop that is necessary to
upregulate Ato levels in an Ato+Da-dependent manner, after which it is needed for lateral
inhibition. The mechanism underlying these two antagonistic functions has, to our
knowledge, remained undefined at the molecular level. Our studies suggest that spatially
controlled phosphorylation of M8 may introduce a ‘time-delay-circuit’. Without this delay Ato
upregulation would be impaired, and Ato levels in the pre-R8 clusters would not achieve the
threshold necessary to adopt the R8 fate. The strong loss of Ato upregulation that is seen
with E(spl)D or upon stage-1 expression of M8* would be consistent with our model, and
underscore the prescient suggestion of Giebel and Campos-Ortega that this region (the
CtD) may impose control over repression.
EGFR and the specification of the R8 cells
While there are numerous lines of evidence for the contribution of MAPK in retinal
determination, the role for the EGFR pathway in R8 selection is still unclear. The
EGFR/MAPK signaling pathway has been suspected to play a role in R8 patterning. For
example, egfr-/- clones display the specification of ‘twinned’ R8s, a phenotype also manifest
in clones of the downstream effectors Ras and Raf (Yang and Baker, 2001). A similar
analysis of MAPK-/- clones has been stymied due to cell lethality. Nevertheless, we note
with interest that a ‘twinned’ R8 phenotype is not seen in clones of pointed (pnt), the nuclear
effector of EGFR signaling, or anterior open (aop or yan), that acts as a repressor (Yang
and Baker, 2003). Moreover, active dual-phosphorylated MAPK (dp-ERK) is detectable in
cells at stage-2/3 of the MF (Kumar et al., 1998), and this staining is lost in egfr-/- clones
(Lesokhin et al., 1999), suggesting that MAPK activation at this stage of the MF is not being
driven by another RTK. Surprisingly, and unlike the canonical mode of EGFR/MAPK
signaling, dp-ERK does not translocate to the nucleus and instead appears cytoplasmic,
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referred to as the ‘cytoplasmic-hold’ (Kumar et al., 2003). This is intriguing, because in this
location active-MAPK would not be able to phosphorylate either Pnt or Yan, which are
constitutively nuclear proteins (Shilo, 2003). The identity of the proteins targeted by this
active cytosolic MAPK has remained unknown. Do these studies suggest that active MAPK
may act to regulate M8 in the cytosol and that this activated protein then enters the nucleus
to mediate repression? While the answers to this question are presently unknown, we note
that the default location of the M8 homolog HES6 is cytosolic in the myogenic program (Gao
et al., 2001), and nuclear localization of this repressor is closely coupled to induction of
differentiation, suggesting that the nucleus is not the default location of (at least) this HES
repressor.
Then how does MAPK phosphorylation precisely affect M8 activity? We have
previously proposed that M8 is an autoinhibited protein, an intramolecular restraint upon
repressor capabilities that keeps the protein in an inactive state (Kahali et al., 2010b;
Karandikar et al., 2004). Surprisingly, the deletion of the CK2 site, which in a sense mimics
the phosphorylation, leads one to propose therefore the simplest interpretation that it is the
CK2 site that itself imposes some protein-protein contact that is responsible for controlling
the onset of repression. However, this variant at an earlier stage of the furrow fails to
perturb the eye field, which now necessitates a simultaneous deletion of the MAPK site
indicating that neither the CK2 nor the MAPK phosphorylation is likely to act as a scaffold or
serve as a basis for secondary modulation. In fact, these phosphorylations may be required
purely at a level of intramolecular protein contact. If so, it is reasonable to suggest that both
CK2 and MAPK act to restrain autorepression, and the data presented with Asp
replacement at both kinase sites as well as the deletion of either kinase site, would suggest
that the protein is under dual control. We think that dual control is a mechanism to allow for
the precise regulation of the protein. One question that has always remained unanswered is
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what triggers the modification of M8 by CK2? This kinase does not respond to extracellular
or intracellular signaling pathways, but clearly does not appear to modify M8 on its own
because co-expression of CK2 and M8 does not pheno-copy the effects of the Asp. Our
studies do not allow us to tell whether CK2 modification acts prior to that of MAPK. In any
event however, given that MAPK activation is exclusively dependent on EGFR pathway
activation, it therefore is reasonable to suggest that the gate-keeping function could well be
mediated by EGFR.
These studies for the first time demonstrate a developmental context under which
the MAPK site in M8 protein is of biological consequence. As shown in the last figure (Fig
10), co-ordinated functions of several kinases (CK2 and MAPK) and phosphatase (PP2A)
control the regulatory output of M8 repression. These PTMs may be a way to balance the
amplitude of the M8 signal or the duration. While phosphorylation by CK2 and MAPK allows
for precise on-set of repressor activity of M8 and thus for R8 selection, de-phosphorylation
by PP2A ensures a rapid inactivation of the protein.
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Materials and Methods
Construction of M8 variants: M8 variants with Ala/Asp substitutions at the known
phosphorylation site for CK2 (Ser159) and/or that predicted for MAPK (Ser151) were
generated by PCR based site-directed mutagenesis. M8 variants harboring deletions of the
CK2 (S159DCD) or MAPK (P149LSP) consensus motifs were generated by inverse-PCR.
In both cases (Ala/Asp or deletion variants), the forward and the reverse primers
incorporated EcoRI and BamHI sites 5’ and 3’ to the coding region, respectively. The
forward primer incorporated a KOZAK consensus (CAAC) immediately 5’ to the ATG codon
for efficient expression. All constructs were fully sequenced to confirm the presence of only
the intended mutations.
Germ line transformation: The Ala/Asp variants of M8 targeting the CK2 and/or
MAPK sites were cloned into the vector pUAST-attB, whereas the deletion variants were
cloned into pUAST (Brand and Perrimon, 1993). Transgenic lines were generated using a
commercial embryo injection facility (BestGene, Inc.). All pUAST-attB constructs were
integrated using the ϕC31-docking site at 68E on the third chromosome (Bateman et al.,
2006). The transgenic lines were verified by PCR amplification and sequencing of the
PUAST-attB construct, and a single molecularly defined line was used in the studies. For
the pUAST-constructs, w+ progeny were identified and the insertion site was mapped by
standard approaches using chromosomes harboring dominant markers. In the case of
pUAST constructs, 10 independent insertions of M8-ΔCK2 and M8-ΔMAPK were generated,
and of these ≥5 have been used in the studies.
Biochemical analysis: Protein-protein interactions were analyzed by the LexAbased version of the yeast interaction trap. The bait and prey constructs were expressed as
C-terminal fusions with DNA-binding domain of LexA and the activation domain (AD) of B42,
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respectively. The yeast strain EGY048p was used to evaluate protein interactions, as
described (Trott et al., 2001).
Fly stocks: The Gal4 drivers were obtained from Bloomington Stock Center
(denoted by the prefix B). These drivers are 109.68Gal4 (B6479), hH10 Gal4 (Fischer-Vize et
al., 1992) scaGal4 (Giebel and Campos-Ortega, 1997). The DER mutant line egfrf24 (B6500)
was also obtained from Bloomington Stock Center. wdbEP3559 flies were a gift from Amita
Sehgal (U. Penn).
Eye and bristle phenotypes: All crosses were performed on standard YeastGlucose medium at 24°C, unless indicated otherwise. Fly heads were dehydrated by
sequential passage through a graded alcohol series for 24 hours each (25%-50%-75%100%), and finally passed through Hexamethyldisalinaze. Heads were mounted on EM
stubs, dried for 24 hours, sputter coated with gold and examined with a JEOL-6400
scanning electron microscope at an accelerating voltage of 10-20kV. Images were
processed with Adobe Photoshop and collated in Adobe Illustrator. The reduced eye was
quantified from ~20 adult flies that were photographed using a Leica MZ16
stereomicroscope equipped with a Leica DFC-480 digital camera. Facet numbers were
counted from TIFF images. A similar approach was used to determine bristle phenotypes.
Eye size (facet counts) and bristle defects were statistically analyzed using Student’s T-test.
Immunostaining and confocal microscopy: Eye imaginal discs were isolated
from late third instar larvae and processed as described (Kavler et al., 1999) with minor
modifications. After isolation, discs were fixed in 4% paraformaldehyde in 1x phosphate
buffered saline (PBS) for 45 minutes at 4°C. After fixation, discs were washed three times
with PBS containing 0.3% Triton X-100 (PBS-TX) for 15 minutes each. The discs were
incubated for 12-14 hours at 4°C in PBS-TX containing primary antibody. The following
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antibodies were used; guinea pig anti-Sens (gift from Hugo Bellen, HHMI-Baylor) at a
dilution of 1:2000 and mouse anti-ELAV (DSHB, Iowa) at a dilution of 1:1000. Following
primary antibody binding, eye discs were washed three times with PBS containing 0.3%
Triton X-100 and then incubated with secondary antibody at room temperature for 2-3 hours.
The secondary antibodies (Molecular Probes) used for are, goat anti-guinea pig-IgG coupled
to Alexa Fluor 633 (1:1000) and goat anti-mouse-IgG coupled to Alexa Fluor 488 (1:1000).
The discs were mounted in 60% glycerol, and viewed on an Olympus FluoView (FV100) for
confocal imaging. Images were acquired every 1um along the apicobasal axis of the discs
and then compressed as a Z-stack without the removal of any layers. Compressed Z-stacks
were exported as TIFF files and collated in Adobe Illustrator.
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Fig. 10: MF specificity of M8-S159D.
(A) Schematic representation of the morphogenetic furrow (MF) depicting the expression
domains of different Gal4 drivers. The cell fates at different stages, spanning the MF are
represented in colored shades. (B) The eye phenotype of CK2 variants (random insertion
lines) driven by two different drivers, scaGal4 and 109-68Gal4 at stage-2/3 of the MF. (C,D)
Scanning EM of adult eye at a magnification of 200x. (C) Overexpression of CK2
phosphomimectic form M8-S159D, at stage-2/3 of the MF perturbs the eye. (D) M8-S159D
fails to generate any eye defect at stage-1 of the MF. (E) Ommatidial (facet) counts were
determined in ≥25 of the indicated genotypes. Asterisk denotes P-value <0.001.
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Fig. 11: Conservation of Ser residues in the P-domain of E(spl)-M8.
(A) The functional domains of E(spl)-M8 are represented by a basic domain (DNA binding),
an HLH domain (dimerization), a second HLH region, the Orange domain (interaction with
Ato/ASC) and a C-terminal WRPW motif (Gro-binding). While these domains are highly
conserved among all the E(spl) members, the length/sequence heterogeneity is largely
confined to the C-terminal domain (CtD), the region between Orange and WRPW. The CtD
has a phosphorylation domain (P-domain) with several conserved Ser residues. The
mammalian Hes6 has additional Asp residues in the CtD (black arrow) (B) Sequence
alignment of P-domain of E(spl)-M8 homologs in 12 Drosophila species, Stalk-eyed fly
(T.dalmani) and the mammalian homolog of E(spl)-M8 in mouse Hes6 and human Hes6.
The blue and yellow shaded boxes meet the consensus for MAPK and CK2 phosphorylation
motifs respectively. Conserved phosphorylatable Ser residues are represented in bold red.
Phylogenetic relationship of E(spl)-M8 of all the 12 Drosophila species are represented at
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the right side of Panel B. (C) The Φc31 M8 phospho variants used for the study. M8S159D represents the CK2 mimic and M8-S151D represents the MAPK mimic. M8S151D+S159D mimics CK2+MAPK dual phosphorylated form. M8-S151A+S159D is the
CK2 phosphomimetic and MAPK refractory form of the protein. Two-hybrid interaction of the
M8 variants with Gro (co-repressor) were measured as Lac Z activity (Miller Units) and
represented as “+” in the table.
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Fig. 12: MAPK refractory but CK2 mimic does not perturb the eye.
(A) M8-S151A+S159D (CK2+no MAPK) fails to generate any eye defect at stage-2 of the
MF. (B, C) Loss of MC’s on the heminotum displayed by M8-S151A+S159D and CK2 mimic
M8-S159D. (D) MAPK mimic (M8-S151D) and dual-kinase mimic (M8-S151D+S159D) elicit
embryonic lethality (EL) when driven at stage-2/3 of MF by scaGal4.
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Fig. 13: Secondary phosphorylation enhances M8 activity.
(A-D) Adult eye phenotype of all the phospho-mimetic variants driven by 109-68Gal4 at
stage-2/3 of the MF. (E) Ommatidial (facet) counts were determined in ≥20 of the indicated
genotypes. Asterisk denote P-value <0.001. (A’-D’) The phosphor-variants elicited MC loss.
(F) Heminotum MC loss was determined in all the four variants. Asterisks denote P-value
<0.001.
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Fig. 14: Phosphomimics perturb R8 birth and differentiation.
Eye disc of the aforementioned genotypes were immunostained with α-Sens (magenta) and
α- ELAV (green) to determine R8 differentiantion and secondary photoreceptor recruitment
respectively. Arrow indicates direction of MF progression. (A) CK2-mimic M8-S159 shows
absence of closely juxtaposed ELAV+ cluster. Note that MAPK mimic M8-S151D (C) and
CK2+MAPK dual mimic M8-S151D+S159D (D) random patches of non-specified and nondifferentiated retinal tissue. On the contrary, M8-S151A+S159D (B) shows uniformity in
Sens+ELAV clusters, akin to WT disc (data not shown).
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Fig. 15: MAPK mutation causes precocious M8 repressor activity at stage-1 of MF.
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(A-C) Adult eye phenotypes of different M8 variants at stage-1 of the MF. Both M8-S151D
(A) and M8-S151D+S159D (B) perturb the eye field whereas M8-S151A+S159D (C) fails to
generate any eye defect at stage-1 of the MF. (A’-C’) 1000x magnification of the
corresponding genotypes in panels (A-C). There are extra IOBs specified for MAPK mimic
(A’) as well as the MAPK+CK2 mimic (B’). The CK2+no MAPK mimic (C’) fails to specify
extra IOBs. Ommatidial (facet) counts were determined in ≥20 adult flies. Asterisk denote Pvalue <0.001.
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Fig. 16: Decreased EGFR levels rescue reduced eye of CK2 mimic only.
(A-B) Scanning EM of adult eye at a magnification of 200x. (A) Overexpression of CK2
phosphomimectic M8-S159D form at stage-2/3 of the MF at an egfr+/+ background perturbs
the eye. (B) M8-S159D when expressed at egfrf24/+ background restores the eye field.
Graph shows ommatidial count of the adult eyes. Data labeled A and B correspond to the
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adult eyes shown in panel (A) and (B). Facet count was determined in ≥20 flies. Asterisk
denotes P-values< 0.001. (A’-B’) Eye discs of genotypes indicated in A and B were
immunostained with α -Sens (magenta) and α - ELAV (green) to assess R8 differentiation
and secondary photoreceptor recruitment. Panel (B”) shows a magnified image of panel
(yellow box in B’) to highlight the rescue of differentiated R8s and Elav clusters. (D,E)
Overexpression of MAPK phosphomimectic M8-S151D and CK2+MAPK dual mimic M8S151+159D at stage-2/3 of the MF at egfrf24/+ background fails to restore the eye field.
Facet count was determined in ≥20 flies. Data labeled D and E correspond to the adult
eyes shown in panel (D) and (E). Asterisk denotes P-values< 0.001.
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Fig. 17: Deletion variants of M8 perturb eye development.
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(A) Schematic representation of the P-domain deletion variants of M8. M8-ΔCK2 lacks the
CK2 motif and M8-ΔMAPK lacks the MAPK motif. The deletion variants were expressed at
stage-1 of the MF driven by hH10Gal4. (B-C) M8-ΔCK2 fails to generate any overt eye defect
(B) whereas M8-ΔMAPK generates a reduced and rough eye phenotype (C). (D-E) At an
egfr+/+ background, M8-ΔCK2 overexpression driven by scaGal4 leads to a rough and
reduced eye (D). The eye defect of M8-ΔCK2 is rescued at a halved dosage of egfrf24/+
background (E). Similar studies involving M8-ΔMAPK was precluded as scaGal4 driving the
deletion variant led to embryonic lethality (see inset Fig 8). (F-G) In order to circumvent the
problem, weaker driver 109-68Gal4 was used which resulted in a rough and reduced eye
phenotype (F) at an egfr+/+ background. The eye defect of M8-ΔMAPK at stage-2/3 was
not rescued in a halved dosage of egfrf24/+ background (G). The graphs at the bottom
panel are for the corresponding genotypes. Ommatidial (facet) count was determined in ≥20
flies. Asterisk denotes P-values< 0.001.
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Fig. 18: MAPK site in M8 may be a target for modulation by PP2A.
(A) Overexpression of widerborst (wdb) rescues the eye defects of CK2 mimic M8-S159D
(adapted from (Bose et al., 2014)). Scanning EM of the adult eye at 200x magnification (BC). Co-expression of Wdb fails to rescue the reduced eye phenotype due to overexpression
of (B) M8-S151D and (C) M8-S151D+S159D. Graph shows ommatidial (facet) counts of
the adult eyes. Data labeled B and C correspond to the adult eye shown in panels B and C.
The +/+ controls for each corresponding genotype are adapted from Fig 3. Facet counts
were determined in ≥20 flies, and asterisk denotes P-values <0.001.
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Fig. 19: Phosphorylation and dephosphorylation regulates M8 repressor activity
during retinal neurogenesis.
Model for M8 regulation. In the auto-inhibited state, the CtD loops back and blocks the HLH
and/ Orange domain thereby prohibiting M8 interaction with Ato. CK2 and MAPK
phosphorylation converts M8 into an active repressor for Ato, whereas PP2A mediates
inactivation, either by a conformational change or by marking the protein for modifications by
unknown targets for proteasomal degradation. The cartoon in the right represents the
spatio- temporal regulation of M8 by phosphorylation and dephosphoryation by all these
different factors in a 48-hr window of MF progression. As all the photoreceptors at stage-1
slowly starts accumulating Ato, M8 is produced at stage-2/3; undergoes post-translational
modification (PTM) by CK2 and MAPK and restricts Ato in R8 photoreceptors. Immediately
after, PP2A restricts M8 activity either by modulating the duration or amplitude of the
repressor protein thereby preventing any abnormal repression.
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CHAPTER 3: Identify the role of P-domain in autoinhibition of M8
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Abstract
During autoinhibition, the C-terminal domain (CtD) of M8 mediates a ‘cis’ interaction
with the residues of the bHLH through the Orange domain. At the time of R8 specification,
M8 undergoes phosphorylation by CK2 at the CtD, which is a necessary step for repressing
the proneural protein Atonal. The CK2 site resides in a region that conserves additional Ser
residues. This region of conserved Ser residues has putative sites for modifications by
other kinases and has been termed as the P-domain (phosphorylation domain). Using
deletion variants of specific kinase motifs and the entire P-domain, we demonstrate that this
Ser-rich region is necessary for autoinhibiting M8. We have also tested this model for
inhibition by co-expressing the CtD-peptide, which rescues the eye and the bristle defects of
the deletion variants. This key regulation by the P-domain is bypassed by the E(spl)D
mutation encoding the truncated protein M8*, which inhibits Ato precociously. Additionally,
we provide evidence that the P-domain may undergo modulation by Slmb, a subunit of E3
ligase, which regulates proteasomal degradation. Together these studies provide evidence
that the P-domain of CtD has a role in autoinhibition of M8 and also assists in protein
clearance in a phosphorylation dependent manner.
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Introduction
The Notch signaling pathway is highly conserved in invertebrates and vertebrates,
and is involved in induction as well as restriction of cell fates. The functions of Notch have
been exceptionally well analyzed during neurogenesis, where it mediates lateral inhibition to
regulate dichotomy between neural versus epidermal cell fate (Artavanis-Tsakonas et al.,
1999; Baonza and Freeman, 2001; Bray, 2006). The two sensory organs of Drosophila,
which have been studied extensively to understand the mechanism of lateral inhibition
include the compound eye and the mechanosensory bristles, such as the macrochaetes
(MC’s), microchaetes (mc’s) and the interommatidial bristles (IOB’s) (Modolell, 1997;
Modolell and Campuzano, 1998; Simpson, 1990). Although different in structure, eye and
bristle development involves similar genes and cell fate/lineage decisions. Studies involving
these two model structures have led to our present day understanding of the core
components of the Notch pathway and how it regulates cell fate specification.
At the onset of neurogenesis, proneural basic-helix-loop-helix (bHLH) activators
encoded by atonal (ato) or the achaete-scute complex (ASC) is expressed in groups of cells,
called proneural clusters (PNCs) (Heitzler et al., 1996; Jarman et al., 1995; Jarman et al.,
1994; Kiefer, 2005; Skeath and Carroll, 1991). While ato is required for eye development,
ASC expression is critical for bristle morphogenesis (Calleja et al., 2002; Campos-Ortega,
1998; Jarman et al., 1995; Jarman et al., 1994). The activities of these proneural proteins
drive the formation of the PNCs, in which all cells have somewhat equal potential to adopt
the neural fate (Dambly-Chaudiere and Vervoort, 1998; Frankfort and Mardon, 2002; Gibert
and Simpson, 2003; Hsiung and Moses, 2002). From each PNC, however, only a single cell
becomes the neural progenitor, the ‘founding’ R8 photoreceptor in case of the eye or the
bristle sensory organ precursor (SOP), while the others are redirected to an alternative fate.
This restriction of the R8/SOP from a PNC is termed lateral inhibition (Axelrod, 2010; Castro
et al., 2005; Simpson, 1990). During this process, the presumptive R8/SOP activates Notch
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in the adjacent cells of the PNCs (the non-SOPs/R8s). Specifically, activation of Notch
results in the cleavage and nuclear translocation of it’s intracellular domain (Nicd), where it
associates with and activates Suppressor of Hairless (Su(H)) leading to the transcription of a
family of basic Helix-loop-Helix (bHLH) repressors, collectively called the Enhancer of split
Complex (E(spl)C) ((Bailey and Posakony, 1995; Lecourtois and Schweisguth, 1995) (Bray,
1997; Delidakis and Artavanis-Tsakonas, 1991). The E(spl) repressors complex with the corepressor Groucho and antagonize Ato/ASC to restrict the R8/SOP fate in all but one cell of
a PNC.
Despite our understanding of the Notch pathway components and the mechanism of
activation of E(spl) genes, our knowledge on the roles of functional domains of these
repressors and their mode of regulation still remains unclear. Given their conserved
structure, a long-standing view is that these proteins are functionaly redundant, and that
repression by these proteins is purely a reflection of their dosage. A body of genetic
evidence contradicts this view. For example, while loss of E(spl)C elicits ectopic R8s/SOPs,
overexpression of the various E(spl) members only affected bristle-SOP fate but R8
specification remained largely unperturbed (Giebel and Campos-Ortega, 1997; Ligoxygakis
et al., 1998; Nakao and Campos-Ortega, 1996). Of the three E(spl) members, M8, Mδ and
Mγ which are expressed in the morphogenetic furrow (MF) during eye development, only Mδ
overexpression elicit loss of R8’s (Ligoxygakis et al., 1999; Nagel et al., 1999). The first line
of evidence that protein dosage of bHLH repressors is insufficient for inhibition of R8 cell
came in light when E(spl)D, a unique dominant allele of m8 elicited dominant loss of R8s
and the eye (Kahali et al., 2009a; Nagel and Preiss, 1999).
The dominant eye defect elicited by E(spl)D allele can be attributed to its enhanced
interaction with and antagonism of Ato (Nagel and Preiss, 1999). It was paradoxical that a
similar result could not be recapitulated by overexpression of full length M8. Detailed study
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revealed that the protein encoded by the E(spl)D allele is a truncated protein called M8*,
which lacks 56 C-terminal residues (Nagel et al., 1999; Tietze et al., 1992). It was this
discovery that led to presciently suggest that the C-terminal domain (CtD) of M8 might have
regulatory influence on its repressor activity (Campos-Ortega, 1997). Later studies show
that the CtD of M8 is phosphorylated by CK2 at a specific motif, a region missing in M8*
(Trott et al., 2001). As a consequence of this post-translational modification (PTM), M8
undergoes a conformational change, which enables it to bind and antagonize Ato.
Replacement of the CK2 phospho-acceptor (Ser159) with a phosphomimetic Asp residue
(M8-S159D aka M8-SD) elicits exacerbated loss of R8s and the eye with a potency akin to
E(spl)D. Moreover, M8-SD interacts with Ato with a binding strength equal to that of M8*.
Consequently it was proposed that the CtD autoinhibits full length M8. Phosphorylation
displaces this intra-molecular interaction permitting repression of Ato. This appears to be
the case because co-expression of non-phosphorylated M8-CtD rescues the reduced eye of
CK2-mimic M8-SD, even though the interaction would be in ‘trans’. A CtD with Asp at the
CK2 site failed to rescue the R8s and eye defect (Kahali et al., 2009b).These results
implicate CK2 as a regulator of R8 selection through the activation of M8 (Karandikar et al.,
2004). Accordingly, loss of CK2 in otherwise wild type flies compromises lateral inhibition
and elicits the specification of excess R8s from the IGs (Bose et al., 2006).
In case of M8, M5, M7, Mγ and the human homolog of E(spl) protein, HES6, the CK2
site is located in a region termed as the P-domain, which reveals the presence of additional
conserved Ser residues. This Ser rich region represents consensus sites for
phosphorylation by MAPK, CK1 and GSK3. In case of HES6, the PxSP motif in its tail
region has already been shown to be a target for MAPK, an effector of EGFR pathway,
although its developmental consequences are presently unknown (Belanger-Jasmin et al.,
2007). Although, mutations in CK1 or GSK3 have no known consequences in R8
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patterning, the role of EGFR in R8 specification has long been suspected. The close
clustering of CK2 and MAPK sites on the CtD raises questions on their role on regulating
repressor activity of M8. Furthermore, recent studies from our lab have shown that
dephosphorylation of M8 by phosphatase PP2A may play a role in antagonizing Notch
signaling (Bose et al., 2014). It is speculated that PP2A may control the amount of active
(non-inhibited) M8, or it may act to control M8 inactivation immediately upon the selection of
single R8s, providing a rapid and potent mechanism to shut off M8. Additionally, a largescale Drosophila protein-protein interaction screen has revealed supernumerary limbs
(Slmbs) to be an interacting partner of M8 (Guruharsha et al., 2012). Slmb is the substrate
specificity subunit of the SCF E3-ubiquitin ligase that targets proteins for degradation via the
26S proteaosome. Modifications of Ser 154, 155 and159 (CK1, GSK3 and CK2 sites
respectively) in the CtD of M8 via phosphorylation may generate a Slmb-binding consensus
motif, thereby eliciting formation of the ‘Slmb-phosphodegron’ which can be then targeted
for degradation. These coordinated phosphorylation-dephosphorylation and the binding of
Slmb for proteasomal degradation may be a method for regulating M8 activity during R8
specification.
In this chapter we have employed deletion variants of M8 protein to explain the
autoinhibition model. We have used deletion variants of CK2-motif, MAPK-motif and Pdomain motif to explain the role of multisite phosphorylation as a mechanism for controlling
regulatory activity or degradation of M8. We have determined that the P-domain plays a
role in the regulating the activity of M8 during R8 specification. Our studies on the rescue of
the eye and bristle defects of ectopic deletion variants with overexpression of the CtDpeptide are consistent with autoinhibition. Moreover, our studies also suggest that an intact
P-domain is necessary for the formation of phosphodegron, which is a necessary step for
degradation of M8. The implications of these findings are discussed (see discussion).
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Results
Deletion variants and their differential roles at stage-1 of the MF
As stated in the introduction (see above), the CtD of M8 has been suggested to play
a role in regulation of M8 during neurogenesis. Studies from the lab have shown that
overexpression of the phosphorylatable CtD variant, M8-CtD, strongly represses the eye
and bristle defects of ectopic M8-S159D at stage-2/3 of the MF. This shows that M8-CtD
retains the autoinhibitory activity and is able to prevent the inappropriate repression of Ato
by CK2 mimetic form M8-S159D. Similar autoinhibitory activity of phosphomimetic CtD
variant M8-SD-CtD was not seen (Kahali et al., 2010b).
To further analyze the role of P-domain in autoinhibition, we have generated deletion
variants of M8. We adopted random integration method to generate M8-ΔCK2, M8-ΔMAPK
and M8-ΔPD deletion lines. We then characterized the in vitro interaction of the variants
with co-repressor Groucho. In a yeast two-hybrid assay, all variants interact robustly with
Groucho (Gro, Fig. 1B), which is essential for M8 repressor activity in vivo.
We next assessed if overexpression of the deletion variants elicit eye defect at
stage-1 of the MF. The expressivity of the endogenous E(spl) genes do not correlate with
stage-1. Hence, it was expected that overexpression of M8 deletion variants, which have
bypassed the need for phosphorylation and is already primed for Ato inhibition, would show
effect at stage-1 of the MF. On the contrary, M8-ΔCK2 overexpression at stage-1 (hH10Gal4)
is without effect (Fig. 1C). This stage-1 inactivity of M8-ΔCK2 was unexpected as Ato levels
are lowest at this point of R8 birth. In contrast, M8-ΔMAPK indeed shows a reduced eye at
stage-1 (Fig. 1D). This activity may reflect the necessity of phosphorylation of M8 at MAPK
site in order to induce its repressor activity. M8-ΔMAPK bypasses the need for
phosphorylation at the CK2 site and is ready to repress Ato at stage-1 of the MF. On the
other hand, since M8-ΔCK2 still has an intact MAPK site, which cannot be phosphorylated
at stage-1 of the MF due to lack of MAPK at that stage, fails to perturb the eye. It was
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expected that M8-ΔPD would perturb the eye with more severity than M8-ΔMAPK, given it is
lacking the entire P-domain, which may be attributed to the structural component of the
autoihibition model. Unfortunately, any assessment with M8-ΔPD at stage-1 was not
possible owing to embryonic lethality of this deletion variant. Lethality was seen even in
crosses conducted at 18C where Gal4 activity is attenuated (Fig. 1 inset)
All three-deletion variants elicit eye defect at stage-2/3 of the MF
We next compared the activity of the deletion variants at stage-2/3 of the MF. To
eliminate position effects, multiple independent lines harboring deletion constructs were
used. The expression of the UAS-constructs were driven with the enhancer trap scaGal4,
that elicits Gal4 expression in stage-2/3 of the MF, where endogenous E(spl) mediates
selection of R8 cells. The expression of M8-ΔCK2 with scaGal4 elicits a reduced eye and
complete loss of IOBs (Fig 2A and 2A’), a phenotype, which correlates with the expression
of the site-specific CK2 phospho-variant, M8-S159D (see Chapter 2). We next tested the
effects of M8-ΔMAPK and M8-ΔPD at the same stage. Unfortunately similar results did not
bear out owing to embryonic lethality elicited by both the variants when expressed with
scaGal4, even at 18C (as shown in Fig. 2 inset). To overcome lethality we used 10968Gal4, a weaker stage-2/3 driver. Expression of M8-ΔCK2 elicited a reduced eye and loss
of the IOBs (data not shown), but not with the same severity as seen with scaGal4. The
difference in severity of the reduced eye may be an effect of stronger strength of scaGal4,
as compared to 109-68Gal4. Both M8-ΔMAPK and M8-ΔPD elicit a strong reduction in eye
size (Fig. 2B and 2C) and also display defects in IOB patterning (Fig. 2B’ and 2C’). No
eye/IOB defects are seen in scaGal4/+ or 109-68Gal4/+ flies or the three M8-deletion lines
on their own. These studies indicate that the MAPK motif is also modulated for regulating
M8 activity. An intact P-domain is necessary to elicit autoinhibitory effects on the protein. In
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absence of the P-domain, M8 can be precociously activated which then antagonizes Ato
and perturbs R8 specification.
M8 deletion variants perturb R8 specification and bristle formation
In order to determine if the deletion variants perturb birth of R8 and secondary
photoreceptors, we next stained the third instar larval eye disc with Senseless (Sens), a
marker for differentiated R8s and ELAV- a pan-neuronal marker. The reduced eye upon
expression of M8-ΔCK2 with scaGal4 (Fig. 3A) reflects strong loss of R8s (Sens+ cells), and
many of the R8s that emerge from the MF poorly sustain Sens expression, and thus
inefficiently recruit secondary (ELAV+) photoreceptors. A few regions of the eye disc are
devoid of closely juxtaposed ELAV clusters, as compared to control discs (data not shown).
These R8s are likely removed by apoptosis, a default fate for uncommitted cells,
contributing to the ‘rough eye’ of M8-ΔCK2 expressing flies (see Fig. 2A).
As expression of M8-ΔMAPK and M8-ΔPD with scaGal4 was lethal, we used 10968Gal4 to enable analysis of those two M8 variants. In contrast to M8-ΔCK2, discs
expressing the M8-ΔMAPK and M8-ΔPD display the inconsistent maintenance of Sens
levels along the AP axis in a greater proportion of R8s (Fig 3B, C). Moreover, significant
regions of the eye disc altogether lack Sens+Elav clusters, a result consistent with the
reduced eye (Fig. 2B, C). Thus the reduced eyes of the variants described in Fig. 2 reflect
defective birth, delayed differentiation and survival of R8s, and impaired secondary
photoreceptor recruitment. It is possible to deduce from the severity of R8 defects as seen
from the three different deletion variants, that M8-ΔCK2 likely acts as a ‘sink’ for modification
by other kinases, which is required for repressor activity of M8. As seen in R8 specification
defect with M8-ΔPD, the need for those modifications are bypassed, which reflect in severe
deformity of the R8 and secondary photoreceptor clusters.
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In addition to the reduced eye, all three M8 deletion variants display a strong loss of
MC’s and mc’s on the thoracic and scutellar regions. This reflects studies showing both
scaGal4 and 109-68Gal4 enhancer trap lines are active in the bristle PNC’s. We quantified
the MC loss in the heminotum region for all three-deletion variants. The severity of
attenuation of MC’s for M8-ΔCK2 with scaGal4 (Fig. 3A’) is comparable to the loss elicited
by M8-ΔMAPK and M8-ΔPD when driven by 109-68Gal4 (Fig. 3B’, 3C’). The loss of mc’s,
however, showed less severity when driven by 109-68Gal4 as compared to scaGal4. The
lack of effects on the mc’s reflects weaker strength of 109-68Gal4. Together, these studies
reveal that the P-domain is important for M8 activity in the eye as well as bristle formation.
The effects of M8-ΔCK2 are sensitive to altered EGFR levels
Studies described in Chapter 2 implicated the importance of MAPK site in regulating
repressor activity of M8 during lateral inhibition. This raises the possibility that M8 may be a
target of activated EGFR signaling during R8 specification. If that is the case, then it is
expected that the retinal defect of the M8-ΔCK2 variant should be sensitive to altered EGFR
dosage, whereas the M8-MAPK and M8-ΔPD variants should be refractory to changes in
EGFR signaling as the MAPK site is already compromised in those two variants.
For this analysis, we used egfrf24, a loss of function (amorphic) allele, which does not
perturb the eye/R8s in the heterozygous state (data not shown) but is lethal when
homozygous. If EGFR pathway indeed regulates the activity of M8, then a decrease in its
level should attenuate the level of active MAPK, and result in hypo-phosphorylation of M8 at
its MAPK site. As mentioned earlier, in such a condition (egfrf24/+ background) the reduced
eye phenotype of M8-ΔCK2 should be suppressed. This prediction bears out as we see that
the severity of reduced eye of M8-ΔCK2 in an egfrf24/+ background is indeed significantly
attenuated when compared to its effects in egfr+/+ background (Fig. 4A). This result is
supported by the qualitative analysis of the eye disc, which shows a strong suppression of
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the R8 defects in an egfrf24/+ background (Fig. 4A’) in comparison to the strong loss of
patterned R8s (Sens+ cells) as seen in egfr+/+ background (Fig. 3A).
A similar analysis was conducted with the M8-MAPK and M8-ΔPD variants, but
utilized the driver 109-68Gal4 due to lethality upon expression with scaGal4 (see Fig. 2
inset). The severity of perturbation of eye defect due to overexpression of these two
variants was indistinguishable in egfr+ versus egfrf24/+ backgrounds (compare between Fig.
2B,C and Fig. 4B,C). Staining of the eye disc with Sens and ELAV display similar neural
hypoplasia reflecting loss of founding R8’s as seen in an egfr+ background (compare Fig
3B,C and Fig. 4B’,C’). Based on this data it can be hypothesized that the two closely
clustered kinase sites, MAPK and CK2, may participate in ‘cis’-inhibition of M8. Since this
interaction is lost when the entire P-domain is deleted, the protein bypasses the necessary
post-translational modifications and is presented as a prematurely activated repressor.
M8-CtD strongly suppresses the eye and bristle defects of all the deletion variants
It has been previously reported that co-expression of the 56 residue peptide from M8
(M8-CtD) rescue the reduced eye and bristle defect of M8-S159D (Kahali et al., 2010b).
Besides recovery of the eye size, it was also shown that co-expression of M8-CtD
significantly restored the hexagonal facet phasing and the position of the IOB’s. Importantly,
rescue does not involve competition between two UAS-constructs for a limiting amount of
Gal4 protein, because no rescue of 109-68Gal4>M8-S159D was evinced upon coexpression of UAS-LacZ (data not shown). We therefore tested for rescue of the reduced
eye of all the deletion variants by co-expressing CtD peptide of M8. Indeed, co-expression
of M8-CtD rescued the reduced eye of M8-ΔCK2, M8-ΔMAPK and M8-ΔPD (Fig.5 A, B, C).
It also significantly restored the position of IOB’s (data not shown). M8-CtD largely restored
the eye field of M8-ΔCK2, almost close to the WT eye, whereas restoration of M8-ΔMAPK
and M8-ΔPD was also significant.
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In addition to the reduced eye, deletion variants also displayed strong loss of the four
scutellar MC’s (Fig. 3), because the enhancer traps, scaGal4 and 109-68Gal4 are active in
the bristle PNC’s (Kahali et al., 2009a; Powell et al., 2004). We wanted to assess whether
this neural defect is modulated by co-expression of CtD-peptide. Indeed, our result shows
that co-expression of M8-CtD peptide restored ~2 scutellar MC’s in each of the deletion
variants (Fig. 5E). It therefore appears that co-expression of M8-CtD peptide can effectively
suppresses both the eye and the bristle defects of the ectopic deletion variants. The
possible explanation for such rescue may be the result of binding of the ectopic M8-CtD (in
‘trans’) to the non-inhibited deletion variants and impairing repression.
P-domain in M8 may be a target for modulation by Slmb
Recently, a Drosophila protein-protein interaction screen has revealed Slmb to be an
interacting partner of M8 (Guruharsha et al., 2012). Slmb, a subunit of the E-3 ubiquitin
ligase, interact with phosphorylated Ser residues mark the protein for proteasomal
degradation. Detailed sequence analysis of the CtD of M8 indicates that phosphorylated
Ser residues at 154-159 may create a consensus for Slmb binding.
We thus tested if Slmb has any effect on the deletion variants by asking whether coexpression of UAS-Slmb modulates their reduced eye effect. The reduced eye of all the
deletion variants upon co-expression of UAS-Slmb (Fig. 6A’, B’, C’) appeared similar to that
in its absence (compare with Fig. 6A, B, C). This is result supported by quantitative analysis
of eye size (Fig. 6D). The eye sizes in the presence of ectopic Slmb were statistically similar
to those in its absence. This suggests that an Slmb cannot target M8 in absence of its Pdomain. The deletion of the CK2 motif takes out one of the target pSer residues for Slmb
interaction, which thus fails to interact with the protein and cannot mark it for proteasomal
degradation. Since, the pSer residue at the MAPK motif is not a target for Slmb binding, it
was expected that co-expression of Slmb will rescue ectopic M8-ΔMAPK eye defect. But
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our predictions did not bear out (compare Fig. 6B and 6B’). We think that dually
phosphorylated M8-CtD (Ser 151+159) serve as a template for hierarchical modification of both
Ser154 and Ser155, by CK1 and GSK3 respectively, forming a consensus for Slmb target.
Since M8-ΔMAPK is missing Ser151, the following Ser residues cannot be phosphorylated,
which then fails to generate Slmb phosphodegron. In summary, we think that an intact Pdomain is essential for Slmb target of M8 and its subsequent degradation.
Discussion
The activities of E(spl) proteins are vital for mediating the effects of inhibitory Notch
signaling via lateral inhibition. Therefore it is important to understand the underlying
mechanism of regulation of E(spl) proteins during neural repression. Previous work from our
lab has demonstrated that the CtD of M8 plays a definite role in autoinhibition of the protein
to prevent its precocious activation (Kahali et al., 2010a). It has been shown that CK2
kinase phosphorylates a specific Ser residue in the CtD, which perhaps sets the protein in
an active state when it can bind and antagonize Atonal during R8 specification (Karandikar
et al., 2004). Further studies, as discussed in Chapter 2 suggest that phosphorylation of M8
by CK2 more likely acts as a conformational ‘gatekeeper’, and that modification by a second
kinase, the MAPK acts as a final activating switch. In a sense, CK2 and EGFR together
may therefore control when and where M8 activity manifests in the developing retina. The
putative role of EGFR in regulating M8 activity was strengthened as our studies show that
the phosphomimetic variants of M8 were responsive to altered EGFR levels (see Chapter 2).
The above data compelled us to look closer and analyze the role of CtD in autoinhibtion of
M8 during neurogenesis. Sequence analysis of the CtD of M8 revealed invariant Ser
residues upstream of the CK2 motif across all the twelve Drosophila species, that diverged ~
50x 106 years (myr) ago. The remarkably conserved stretch of Ser residues in the CtD has
been aptly termed the P-domain (phosphorylation domain) as it may be targeted by other
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kinases. The P-domain of M8, M5 and M7 are the only conserved region in the CtD, which
is otherwise variable in length and sequence between the different members. A similar Pdomain is also present in human HES6, which has been shown to be regulated by CK2 in a
manner akin to M8 (Gratton et al., 2003a). Although the developmental consequences of
phosphorylation of the other Ser residues in the P-domain of HES6 are presently unknown,
it provides us a window of opportunity to investigate and understand the role of P-domain in
autoinhibition.
The studies we present here directly test the role of P-domain in autoinhibition model
in two relevant developmental contexts, the eye and the bristle. We have provided multiple
lines of evidence that the P-domain, which has conserved Ser residues, undergoes
modifications by different kinases to relieve autoinhibitory effects on M8. In addition, the
phosphorylated P-domain is suspected to play a role in formation of ‘phosphodegron’, which
is a necessary step for protein degradation and clearance.
Our first line of evidence that P-domain may be involved in repression of M8 comes
from our deletion variant studies. If CtD autoinhibits M8 in a phosphorylation-dependent
manner one might expect deletion of the CK2 motif should render M8 hyperactive. Indeed,
M8-ΔCK2, which lacks just the CK2 consensus site (S159DCD) (Fig.1), perturbs the eye, but
only in a stage-specific manner. It elicits a reduced eye when expressed at stage-2/3 of the
MF (Fig. 2), but fails to do so at stage-1 (Fig.1). The inactivity of M8-ΔCK2 at stage-1
reveals that this protein is not constitutively active, raising the possibility that it requires
additional conformational modifications, which may occur at stage-2/3. The presence of a
consensus MAPK site in the CtD could provide a means for full activation of M8 by
EGFR/MAPK signaling at stage-2/3 of MF. To understand the role of the MAPK motif and
the P-domain in autoinhibiton, the deletion variants M8-ΔMAPK and M8-ΔPD were
overexpressed in a similar manner at stage-1 and stage-2/3 of the MF. The MAPK and P-
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domain deletion variants both perturb the eye at stage-2/3 of the MF (Fig. 2). These are in
accordance with the theory that due to the deletion of the kinase-specific motifs, the proteins
can by-pass the need for post-translation modification and act as a repressor and suppress
Ato immediately. The overexpression of M8-ΔMAPK variant also elicits eye defect at stage1 of the MF. The most parsimonious interpretation for such a result is that perhaps M8ΔMAPK, which is already in a hyperactive state, can precociously repress Ato, even at
stage-1 of the MF (Fig. 1) where Ato levels are lowest. If the mechanism of autoinhibition is
dependent on phosphorylation then overexpression of M8-ΔPD at stage-1 should have
elicited more severe eye defect. Unfortunately, analysis of M8-ΔPD at stage-1 did not bear
out owing to its embryonic lethality (Fig. 1).
Secondly, the rescue of the severely reduced eye of the M8 deletion variants by CtDpeptide, an ectopically expressed subdomain of M8, points to the fact that indeed the Pdomain is part of the contact-dependent regulatory mechanism between the HLH and/
Orange domain and the CtD of the protein. It would therefore seem to be the case that the
ectopically expressed CtD peptide binds (in ‘trans’) to the non-inhibited deletion variants and
attenuates their interaction with Ato. Consequently, Ato level would rise to a specific
threshold to confer the R8 fate, which would increase eye size (facet numbers), as seen in
our result (Fig. 5).
Additional role of P-domain in M8 degradation can be speculated from Slmb
overexpression studies. The region between the MAPK and CK2 consensus motifs has two
conserved Ser residues. A bioinformatics study revealed that these two residues could be
targeted for modifications by CK1 and GSK3. A large -scale Drosophila protein-protein
interaction in S2 cells revealed M8 as an interaction partner with Slmb (Guruharsha et al.,
2012). Hence, it is of interest to note that phosphorylation of the additional Ser residues is
predicted to generate a strong site for Slimb/β-TrCP binding, which can then promote
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proteasomal degradation for M8, providing a possible mechanism for clearance of M8 from
the MF. A study in our lab revealed that co-expression of Slmb can rescue the reduced eye
phenotype of ectopic M8-S159D, a CK2 mimic of M8 (Majot and Bidwai, personal
communication). The most parsimonious explanation is, since the additional Ser residues in
the P-domain of M8-S159D are intact, they can undergo modifications by CK1 and GSK3,
generating the Slmb phosphodegron, leading to the subsequent removal and clearance of
ectopic M8-S159D. If this same logic were applied in case of the deletion variants, one
would think that the perturbation of eye displayed by M8-ΔPD, which does not have the
target Ser residues for Slmb binding, will not be rescued by Slmb overexpression. Indeed
that is the case. The eye defects of M8-ΔPD cannot be modulated by co-expression of
Slmb (Fig. 6). In addition we see similar results with M8-ΔCK2 and M8-ΔMAPK. This would
suggest that a hierarchical phosphorylation is needed to generate a putative Slmb-binding
site and since both these deletion variants are missing one of the consensus motifs for
phosphorylation, it may disrupt subsequent modifications of the remaining Ser residues,
leading to impairment of Slmb binding and generation of a stable phosphodegron.
Our studies indicate that the P-domain in M8 has two modes of action. The first one
is to autoinhibit bHLH and/Orange domain through intramolecular binding, thus preventing
inappropriate association with Ato. This theory is in concordance with the activity of M8*, a
protein which lacks the CtD and elicits eye defect when ectopically expressed. Similar eye
defects are not mimicked by expression of full length M8, which strongly suggest that the
truncation triggers the dominant behavior. Thus, it is imperative that M8 must have an intact
P-domain to elicit autoinhibitory effects. Second mode of action is to provide a mechanism
for rapid clearance of the protein after it has repressed Ato during lateral inhibition. Based
on the various modifications the P-domain in CtD undergoes, an epistatic model for
regulation of M8 through multisite phosphorylation has been suggested (Fig. 8). As
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mentioned earlier, dual phosphorylation of M8 by CK2 and MAPK sets the protein in an
active state, which can then repress Ato. Phosphorylation of the residues 159 and 151 by
CK2 and MAPK respectively, may prime M8 for progressive phosphorylation at residues 154
and 155. Previous work from our lab has suggested that phosphatase PP2A can
dephosphorylate M8 at Ser 151 and controls rapid inactivation of the protein (Bose et al.,
2014). Slmb can target the other three phosphorylated residues in P-domain (154, 155 and
159) facilitating ubiquitinylation and proteasomal degradation (Fig. 8). This tandem
employment of PP2A and Slmb provides a mechanism for rapid reduction in E(spl) activity.
Endogenous M8 is non-functional at stage-4 of the MF as R8 specification is complete by
then. If so, the deletion variants should have no effect at stage-4 of the MF. But our studies
reveal otherwise. The deletion variants effect eye development even at stage-4 of the MF
(Fig. 7). It is possible that the deletion variants lacking the consensus Ser residues for
formation of Slmb phosphodegon are not targeted for proteasomal degradation and
subsequent rapid clearance and thus remain in the MF even after their inhibitory effects
during R8 specification has been realized. It is quite likely that these ectopic deletion
variants are targeting other proteins in the secondary photoreceptor specification pathway
and eliciting perturbation of the eye, as we see in our data. This mode of control via
phosphorylation followed by rapid inactivation and/or clearance provides a mechanism for
control of M8 activity levels during R8 specification.
Future studies to identify the site on the HLH or Orange motif/residues mediating this
interaction with P-domain will be required to fully reveal the mechanism(s) of regulation of
M8 during neural repression. The relevance of this mechanism to other E(spl) members will
define the ‘qualitative’ difference between them and also help understand the mechanisms
underlying repression by this group of bHLH proteins.
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Materials and Methods
Construction of M8 deletion variants: Three M8 deletion variants were generated by
inverse-PCR. M8-ΔCK2 variant harbors the deletion of the CK2 motif (S159DCD), M8ΔMAPK variant is missing the MAPK (P149LSP) motif and M8-ΔPD variant is missing the
entire P-domain (P149LSPASSGYHSDCD). All the three deletion constructs were amplified
by PCR using custom forward and the reverse primers incorporating EcoRI and BamHI sites
5’ and 3’ to the coding region, respectively. The forward primer incorporated a KOZAK
consensus (CAAC) immediately 5’ to the ATG codon for efficient expression. All constructs
were fully sequenced to confirm the presence of only the intended mutations.
Germ line transformation: For in vivo expression, all the three deletion constructs were
cloned into pUAST. Transgenic lines were generated using a commercial embryo injection
facility (BestGene, Inc.). w+ progeny were identified and the location of the insertion sites
for the different variants were mapped by standard approaches using chromosomes
harboring dominant visible markers. At least 10 independent insertions of M8-ΔCK2, M8ΔMAPK and M8-ΔPD were generated, and of these ≥5 have been used in the studies.
Biochemical analysis: Protein-protein interactions were analyzed by the LexA-based
version of the yeast interaction trap (Gyuris et al., 1993). The bait and prey constructs were
expressed as C-terminal fusions with DNA-binding domain of LexA and the activation
domain (AD) of B42, respectively. The yeast strain EGY048p was used to evaluate protein
interactions, as described (Trott et al., 2001). LacZ activity was determined for at least three
independent transformants, each in triplicate.
Fly stocks: The Gal4 drivers were obtained from Bloomington Stock Center (denoted by the
prefix B). These drivers are 109.68Gal4 (B6479), hH10 Gal4 (Huang and Fischer-Vize,
1996), scaGal4 (Giebel and Campos-Ortega, 1997). The DER mutant line egfrf24 (B6500)
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was also obtained from Bloomington Stock Center. UAS-Slmb flies were obtained from
Bloomington Stock Center.
Eye and bristle phenotypes: All crosses were performed on standard Yeast-Glucose
medium at 24°C, unless indicated otherwise. Fly heads were dehydrated by sequential
passage through a graded alcohol series for 24 hours each (25%-50%-75%-100%), and
finally passed through Hexamethyldisalinaze. Heads were mounted on EM stubs, dried for
24 hours, sputter coated with gold and examined with a JEOL-6400 scanning electron
microscope at an accelerating voltage of 10-20kV. Images were processed with Adobe
Photoshop and collated in Adobe Illustrator. The reduced eye was quantified from ~20 adult
flies that were photographed using a Leica MZ16 stereomicroscope equipped with a Leica
DFC-480 digital camera. Facet numbers were counted from TIFF images. A similar
approach was used to determine bristle phenotypes. Eye size (facet counts) and bristle
defects were statistically analyzed using Student’s T-test.
Immunostaining and confocal microscopy: Eye imaginal discs were isolated from late
third instar larvae and processed as described (Kavler et al., 1999) with minor modifications.
After isolation, discs were fixed in 4% paraformaldehyde in 1x phosphate buffered saline
(PBS) for 45 minutes at 4°C. After fixation, discs were washed three times with PBS
containing 0.3% Triton X-100 (PBS-TX) for 15 minutes each. The discs were incubated for
12-14 hours at 4°C in PBS-TX containing primary antibody. The following antibodies were
used; guinea pig anti-Sens (gift from Hugo Bellen, HHMI-Baylor) at a dilution of 1:2000 and
mouse anti-ELAV (DSHB, Iowa) at a dilution of 1:1000. Following primary antibody binding,
eye discs were washed three times with PBS containing 0.3% Triton X-100 and then
incubated with secondary antibody at room temperature for 2-3 hours. The secondary
antibodies (Molecular Probes) used for are, goat anti-guinea pig-IgG coupled to Alexa Fluor
633 (1:1000) and goat anti-mouse-IgG coupled to Alexa Fluor 488 (1:1000). The discs were
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mounted in 60% glycerol, and viewed on an Olympus FluoView (FV100) for confocal
imaging. Images were acquired every 1um along the apicobasal axis of the discs and then
compressed as a Z-stack without the removal of any layers. Compressed Z-stacks were
exported as TIFF files and collated in Adobe Illustrator.
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Fig. 20: Deletion variants and their MF specificity.
(A) The functional domains of E(spl)-M8 are represented by a basic domain (DNA binding),
an HLH domain (dimerization), a second HLH region, the Orange domain (interaction with
Ato/ASC) and a C-terminal WRPW motif (Gro-binding). Schematic representation of the
random deletion mutations of M8 used for the study. M8-ΔCK2 lacks the CK2 motif, M8ΔMAPK lacks the MAPK motif and M8-ΔPD lacks the entire P-domain. (B) Two-hybrid
interaction of the M8 deletion variants with Gro (co-repressor) was measured as Lac Z
activity. (C) Overexpression of M8-ΔCK2 fails to generate any eye defect at stage-1 of the
MF. (D) M8-ΔMAPK perturbs the eye at stage-1 of the MF. Note that any study at this
stage with M8-ΔPD was precluded owing to embryonic lethality (EL). (C’,D’)1000x
magnification of the corresponding genotypes in panels (C-D). (E) Ommatidial (facet)
counts were determined in ≥25 of the indicated genotypes. Asterisk denotes P-value <0.001.
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Fig. 21: Deletion variants enhance M8 activity at stage-2/3 of MF.
(A-C) Adult eye phenotypes of different M8 deletion variants at stage-2/3 of the MF.
Overexpression of M8-ΔCK2 with scaGal4 perturbs the eye. Note that overexpression of
M8-ΔMAPK and M8-ΔPD with scaGal4 leads to EL (embryonic lethality) owing to which the
study was performed with 109-68Gal4. Magnification is at 200x. (A’-C’) 1000x
magnification of the corresponding genotypes in panels (A-C). There are extra no IOBs for
specified for M8-ΔCK2 (A’), whereas, both M8-ΔMAPK (B’) and M8-ΔPD (C’) shows missing
as well as extra IOBs. (D) Ommatidial (facet) counts were determined in ≥25 of the
indicated genotypes.
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Fig. 22: Perturbation of R8 birth and differentiation and bristle formation at stage-2/3
of MF.
Eye disc of the aforementioned genotypes were immunostained with α-Sens (magenta) and
α- ELAV (green) to determine R8 differentiantion and secondary photoreceptor recruitment
respectively (A-C). Arrow indicates direction of MF progression. Note that all three-deletion
variants show random patches of non-specified and non-differentiated retinal tissue at
stage-2/3 of the MF. (A’-C’) The deletion variants elicit loss of macrochaetes (MC’s) and
microchaetes (mc’s) with similar potency. These effects on the MC’s/mc’s reflect expression
of scaGal4/109-68Gal4 in proneural clusters that give rise to these bristle types.
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Fig. 23: Decreased level of EGFR rescue reduced eye of M8-ΔCK2 only.
(A) Overexpression of M8-ΔCK2 at egfrf24/+ background restores the eye field.
Overexpression of (B) M8-ΔMAPK and (C) M8-ΔPD at stage-2/3 of the MF at egfrf24/+
background fails to restore the eye field. (A’-C’) Eye discs of genotypes indicated in A,B
and C were immunostained with α -Sens (magenta) and α - ELAV (green) to assess R8
differentiation and secondary photoreceptor recruitment. Facet count was determined in
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≥25 flies. Data labeled A, B and C corresponds to the adult eyes shown in panel (A-C).
Asterisk denotes P-values< 0.001. Note that the data was compared to eye facet count of
the over-expression study adapted from Fig. 2.
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Fig. 24: M8-CtD suppresses the eye and bristle defects of deletion variants.
(A) Schematic representation of the functional domains of M8 and M8-CtD. The C-terminal
domain (CtD) peptide encompasses residues 123-179 of full length M8 and harbors the
entire P-domain with intact MAPK and CK2 phosphorylation sites along with the terminal
Gro-binding site. (B) Rescue of the reduced eye of scaGal4> M8-ΔCK2 upon co-expression
of the CtD. Magnification is at 200x. (C-D) Rescue of the reduced eye of 109-68Gal4> M8MAPK and 109-68Gal4> M8-PD upon co-expression of the CtD. (E) Ommatidia facet
counts were determined in ≥25 of the indicated genotypes. (F) Suppression of the MC
defects of the different genotypes upon co-expression of the CtDs. Numbers to the right
denote the average scutellar MC count in corresponding number of flies.
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Fig. 25: P-domain in M8 may be a target for modulation by Slmb.
Scanning EM of the adult eye at 200x magnification (A-C). Reduced eye phenotypes of the
deletion variants at stage-2/3 of the MF. (A’-C’) Co-expression of Slmb fails to rescue the
reduced eye phenotype due to overexpression of (A) M8-ΔCK2, (B) M8-ΔMAPK and (C)
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M8-ΔPD. Graph shows ommatidial (facet) counts of the adult eyes. Facet counts were
determined in ≥20 flies, and asterisk denotes P-values <0.001.
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Fig. 26: Deletion variants perturb the eye at stage-4 of the MF.
Scanning EM of the adult eye at 200x magnification. The adult eye of the deletion variants
expressed at stage-4 of the MF with gmrGal4. (A) The M8-ΔCK2 variant shows a rough eye
phenotype whereas M8-ΔMAPK (B) and M8-ΔPD (C) both shows severely reduced eye.
Graph shows ommatidial (facet) counts of the adult eyes. Facet counts were determined in
≥20 flies. (A’-C’) 1000x magnification of the corresponding genotypes in panels (A-C). All
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three variants show ‘blueberry’ phenotype represented by ‘sunken’ ommatidia. M8-ΔCK2
(A’) shows a more muted phenotype as compared to M8-ΔMAPK (B’) and M8-ΔPD (C’)
shown by dotted circles. In panel (A’) the arrow represents fused ommatidia.
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Fig. 27: Epistatic model of M8 activity in the MF.
Model shows the P-domain of M8 with conserved Ser residues (in green). The four Ser
residues are phosphorylated in an epistatic manner. The Slmb protein recognizes the
phosphorylated Ser residues at 154, 155 and 159. Inset shows consensus motif for Slmb
recognition. The schematic representation of different states of M8 has been shown. At
autoinhibited state, P-domain blocks HLH and/Orange domain. MAPK and CK2
phosphorylation sets the protein at an active state, followed by additional modulation by CK1
and GSK3. M8 can then be rapidly inactivated by dephosphorylation by PP2A and finally
targeted for proteasomal degradation by formation of Slmb phosphodegron.
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